MOLECULAR BASIS FOR BLOOD GROUP POLYMORPHISM
TECHNOLOGIES INVOLVED IN MOLECULAR BLOOD GROUP GENOTYPING
MOLECULAR TESTING FOR PLATELET AND GRANULOCYTE ANTIGENS
FETAL BLOOD GROUP GENOTYPING
APPLICATION OF RECOMBINANT ANTIGENS TO BLOOD GROUP DIAGNOSTICS
IN VITRO GENETIC MANIPULATION TO DESIGN RED CELLS: TODAY AND TOMORROW
KEY ELEMENTS OF A QUALITY MANAGEMENT SYSTEM, ITS TOOLS AND OBJECTIVES
THE BUILDING BLOCKS OF A QUALITY MANAGEMENT SYSTEM, EXPERIENCES FROM SOUTH AFRICA
THE MANAGEMENT OF NON-CONFORMITIES IN BLOOD ESTABLISHMENTS
QUALITY INDICATORS IN TRANSFUSION MEDICINE: THE BUILDING BLOCKS
THE EUBIS MANUAL AND TRAINING GUIDE. GUIDELINES AND STANDARDS FOR QUALITY MANAGEMENT AND INSPECTION OF BLOOD ESTABLISHMENTS
QUALITY RISK MANAGEMENT: A VALUABLE TOOL IN IMPLEMENTING, MAINTAINING AND IMPROVING A QUALITY MANAGEMENT SYSTEM
CURRENT CONCEPTS IN TRANSFUSION TRANSMITTED INFECTIOUS DISEASES
CURRENT CONCEPTS IN SEROLOGICAL TESTING - TTID
CURRENT CONCEPTS IN MOLECULAR TESTING - TTID
CURRENT CONCEPTS IN PRE-TRANSFUSION SEROLOGICAL COMPATIBILITY TESTING
STEPS FOR A SAFETY CLINICAL TRANSFUSION
COMPLICATIONS OF THE TRANSFUSION OF BLOOD AND BLOOD COMPONENTS
APPROPRIATE USE OF BLOOD AND BLOOD COMPONENTS
HAEMOVIGILANCE
CHANGING EDUCATIONAL PARADIGMS IN TRANSFUSION MEDICINE
SURVEILLANCE AND MANAGEMENT OF ERRORS IN THE TRANSFUSION CHAIN: ADDRESSING THE SINGLE BIGGEST THREAT TO TRANSFUSION SAFETY
UNITED STATES DONOR HEMOVIGILANCE SYSTEM: MECHANISM FOR NATIONWIDE REPORTING
THE PORTUGUESE HAEMOVIGILANCE WEB SITE
PROBLEMS WITH IDENTIFICATION OF SERIOUS ADVERSE EVENTS IN THE POLISH BLOOD TRANSFUSION SERVICE
UPDATE ON BACTERIAL PRE-RELEASE TESTING OF PLATELETS - THE AUSTRALIAN RED CROSS BLOOD SERVICE CLINICAL EXPERIENCE
AUTOLOGOUS BONE MAROW MONONUCLEAR CELL TRANSFER AFTER ACUTE MYOCARDIAL INFARCTION AND IN CHROINIC ISCHAEMIC CARDIOMYOPATY - INITIAL EXPERIENCE IN A PORTUGUESE CENTER
INFUSION OF EX VIVO EXPANDED HUMAN CORD BLOOD CD4+CD25+ - DERIVED T REGULATORY CELLS CAN PREVENT ACUTE GRAFT-VS.-HOST DISEASE IN A MHC-MISMATCHED GVHD MOUSE MODEL
EXPANSION OF CD34+ UMBILICAL CORD BLOOD IN 3DIMENTIONAL CULTURE MEDIA ON MESENCHYMAL STEM CELL COATED SCAFFOLDS
ANTITHYMOCYTE GLOBULIN THERAPY IMPAIRS THE BENEFICIAL IMPACT OF KIR LIGAND MISMATCHES IN HAEMATOPOETIC STEM CELL TRANSPLANTATION
VIRAL TRANSMISSION RISK IN INDIVIDUAL DONATION NAT SCREENED BLOOD DONORS IN CATALONIA, SPAIN
A ONE-YEAR EXPERIENCE WITH THE COMPLETELY AUTOMATED, BARCODE-CONTROLLED MINI-POOL NAT EXTRACTION SYSTEM ZELOS X100
POSSIBLE TRANSMISSION OF OCCULT HEPATITIS B VIRUS INFECTION IN SPITE OF NON-REACTIVE INDIVIDUAL-DONATION NUCLEIC ACID TESTING
THE IMPACT OF IRON OVERLOAD ON SUSTAINED VIROLOGICAL RESPONSE IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS WITH HCV INFECTION
CORRELATES OF MOLECULAR IMMUNE RESPONSES AND CLINICAL FACTORS TO SPONTANEOUS RECOVERY AND CHRONIC HEPATITIS C VIRUS INFECTION FROM BLOOD DONORS IN CHINA
USING NEW METHODS FOR ESTIMATING RESIDUAL RISKS OF TRANSFUSION-TRANSMITTED HIV-1 AND HVC INFECTIONS IN FRANCE
KETI, A NOVEL HIGH INCIDENCE ANTIGEN IN THE KELL BLOOD GROUP SYSTEM: A SEROLOGICAL AND MOLECULAR STUDY
MOLECULARGENETIC CHARACTERIZATION OF BLOOD GROUPS WITH PROBLEMS IN SEROLOGICAL TESTING: A RETROSPECTIVE ANALYSIS OF SIX YEARS BLOOD GROUP GENOTYPING IN NORTHERN GERMANY
WIDESPREAD STUDY ON THE RHD VARIANTS IN ITALY
GENETIC BACKGROUND OF NOR POLYAGGLUTINATION
HUMAN CORD BLOOD REPROGRAMMED INTO EMBRYONIC-LIKE STEM CELLS
DEFINITION OF EMERGING INFECTIOUS DISEASES
ARBOVIRUSES AND TRANSFUSION TRANSMITTED DISEASES
XMRV, Q FEVER AND OTHER AGENTS
CHALLENGES IN TESTING FOR PLATELET-RELATED ADVERSE EVENTS
PLATELET-DERIVED IL-27 AND SOLUBLE OX40L ASSOCIATED WITH ACUTE TRANSFUSION REACTIONS
PREVENTION OF ALLOIMMUNE PLATELET REFRACTORINESS IN A DOG PLATELET TRANSFUSION MODEL
A CASE OF RECIPIENT DERIVED HLA, HPA-5A AND HPA-15A ALLOANTIBODIES IN THE SETTING OF AN ALLOGENEIC STEM CELL TRANSPLANTION: CHALLENGES FOR TRANSFUSIONAL SUPPORT AND CONSEQUENCES FOR PLATELET RECOVERY
DETECTION OF CYTOKINES IN SUPERNATANT OF PLATELET-PRODUCTS
COST-EFFECTIVENESS OF ADDITIONAL BLOOD SCREENING TESTS IN THE NETHERLANDS
STRUCTURAL ORGANIZATION OF BLOOD TRANSFUSION SERVICES IN PAKISTAN - TECHNICAL ASSISTANCE IMPLEMENTATION PHASE.
ORGANIZATION OF A NATIONAL BLOOD TRANSFUSION SERVICE IN CAPE VERDE QUESTIONS AND PROBLEMS
SUCCESSFUL CHANGE MANAGEMENT - IMPROVING THE VALIDATION PROCESS THROUGH THE IMPLEMENTATION OF GAMP5 AT THE WELSH BLOOD SERVICE
THERAPEUTIC APHERESIS
TAILORED BLOOD COLLECTIONS
GENE EXPRESSION PROFILE OF IMMUNE CITOKYNES IN PATIENTS WITH REUMATHOID ARTHRITIS UNDERGOING TREATMENT WITH IMMUNOADSORTIVE GRANULOCYTE/MACROPHAGE APHAERESIS
IMPACT OF IMMEDIATE OR DELAYED HOLD TIME PRIOR TO PLATELET ADDITIVE SOLUTION ADDITION ON THE IN-VITRO QUALITY OF APHERESIS PLATELETS
REDUCTION OF ISOAGGLUTININ TITERS EMPLOYING COMBINED USE OF DOUBLE-FILTRATION PLASMAPHERESIS AND TOTAL PLASMA EXCHANGE FOR ABO-INCOMPATIBLE RENAL TRANSPLANTATION
HOW TO IMPROVE BLOOD DONATION IN THE EUROPEAN UNION
SUCCESS IN CATALONIA FROM WORLD BLOOD DONOR DAY 2010
THE APPLICATION OF ACTION RESEARCH PROJECT IN PROMOTING VOLUNTARY BLOOD DONATION IN STUDENTS' POPULATION
THE WHOLE IS GREATER THAN THE SUM OF ITS PARTS
MATERNAL ANTIBODY TITRATION AS A PREDICTIVE PARAMETER FOR FETAL STATUS AND THERAPY EFFECTIVENESS IN PREGNANCIES ASSOCIATED WITH ALLOIMMUNE THROMBOCYTOPENIA
NEW INSIGHTS IN FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
TOWARDS IMMUNOLOGICAL UNDERSTANDING OF FOETAL/ NEONATAL ALLOIMMUNE THROMBOCYTOPENIA BASED ON A STUDY OF MORE THAN 100,000 PREGNANCIES?
NON-INVASIVE FETAL HPA-1A GENOTYPING FROM THE MATERNAL PLASMA DNA: DEVELOPMENT AND VALIDATION OF A NOVEL STRAIGHTFORWARD APPROACH
DEVELOPMENT OF NOVEL REAGENTS TO STUDY THE PRESENTATION OF HPA-1A PEPTIDE IN THE CONTEXT OF HLA-DRA/DRB3*0101 BY MATERNAL ANTIGEN PRESENTING CELLS
3D-S11–01
UNIFORM EXAMINATION OF STEM CELL DONORS
CELLULAR THERAPY PRODUCTS QUICK RELEASE ASSAYS: GENOMIC STABILITY
CELLULAR THERAPY PRODUCTS QUICK RELEASE ASSAYS: MICRO-BIOLOGICAL SAFETY
AABB's CELLULAR THERAPY INITIATIVES IN 2011
THE EFFECT OF CHANGE IN TESTING STRATEGY AND INCREASING THE BLACK DONOR BASE ON THE HIV WINDOW PERIOD TRANSMISSION RISK IN SOUTH AFRICA: A FIVE YEAR ANALYSIS
HIV RISK IN BLOOD DONORS: A COMPARISON BETWEEN REPLACEMENT AND VOLUNTARY DONORS IN BRAZIL
WEST NILE VIRUS (WNV) OUTBREAK IN GREECE AND BLOOD SAFETY MEASURES
SCREENING FOR X/P-MLV RELATED VIRUS SEQUENCES IN CANADIAN PATIENTS WITH MULTIPLE BLOOD TRANSFUSIONS
RISK PRIORITIZATION OF THE POTENTIAL THREAT OF EMERGING INFECTIONS TO BLOOD SAFETY
XMRV PROVIRAL DNA PREVALENCE IN BLOOD DONORS AND CHRONIC FATIGUE SYNDROME PATIENTS (CATALONIA, SPAIN)
GUIDELINES VERSUS EVIDENCE BASED TRANSFUSION MEDICINE
PROPHYLAXIS IN HAEMOPHILIA AND OTHER INHERITED BLEEDING DISORDERS
CRITICAL BLEEDING/MASSIVE TRANSFUSION AND PERIOPERATIVE PATIENT BLOOD MANAGEMENT GUIDELINES
CLINICAL AUDIT OF PLATELET USE IN FOUR AUSTRALIAN STATES AND TERRITORIES
VALIDATION OF AN ASA-PCR ASSAY FOR COUMARIN PHARMACOGENOMICS
FEASIBILITY AND SAFETY OF MULTICOMPONENT APHERESIS
EVALUATION OF THE CONCENTRATION OF PLATELET GROWTH FACTORS IN PLATELET CONCENTRATE (PC), THE BASIC COMPONENT OF PLATELET-GEL
EVALUATION OF A RED CELL IN LINE FILTER FOR FRESHAND OVERNIGHT-STORED WHOLE BLOOD
COMPARISON OF TWO VALIDATIONS OF POOLEDW HOLE BLOOD DERIVED BUFFY-COAT PLATELET CONCENTRATES, LEUCOCYTES DEPLETED; FIRST SAVEDIN PLASMA, SECOND IN PLATELET ADDITIVE SOLUTION
VALORIZATION OF OUTDATED BLOOD PRODUCTS FOR REGENERATIVE MEDICINE
PATHOGEN INACTIVATION: CURRENT STATUS AND IMPLEMENTATION CONSIDERATIONS
TREATMENT OF PLATELET CONCENTRATES WITH THEMIRASOL PATHOGEN REDUCTION PROCESS ACTIVATES PLATELET KINASES
VALIDATION AND IMPLEMENTATION OF THE INTERCEPT BLOOD SYSTEM FOR PLATELETS FOR PATHOGEN INACTIVATION OF APHERESIS AND BUFFY-COAT PRODUCTS AT ONE OF THE BIGGEST REGIONAL BLOOD-CENTERS OF SWITZERLAND
POLYMERASE CHAIN REACTION INHIBITION ASSAY DOCUMENTING THE PATHOGEN REDUCTION PROCESS OF PLATELET CONCENTRATES TREATED BY UVC IN THE THERAFLEX UV-PLATELETS SYSTEM
PHARMACOKINETICS STUDY OF MINIPOOLSOLVENT/DETERGENT-FILTERED (S/D-F)CRYOPRECIPITATE FVIII PREPARED IN A CE-MARKEDMEDICAL DEVICE
THE MINIMUM REQUIREMENTS FOR RED CELL SEROLOGICAL TESTING
DIFFICULTIES IN IMMUNOHEMATOLOGY
LYOPHILIZATION AND STABILIZATION OF TRANSFECTED CELLS EXPRESSING LOW-INCIDENCE BLOOD GROUP ANTIGENS: NEW METHODS FACILITATING THEIR USE AS REAGENT-CELLS
PX2: A NEW BLOOD GROUP ANTIGEN WITH IMPLICATIONS FOR TRANSFUSION RECOMMENDATIONS IN P1K AND P2K INDIVIDUALS
Meanings in Medicine: from lab to body to narrative
MALARIA IN THE BLOOD SUPPLY IN AFRICA: IS IT A PROBLEM?
FOLLOW-UP OF ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION IN BLOOD DONORS FROM ANENDEMIC AREA
UPDATE ON THE IMPACT OF MALARIA DEFERRALS INTHE U.S.: CONSIDERATIONS FOR A MORE BALANCEDALGORITHM
PERFORMANCE OF THE RAPID PAN GENERA DETECTION(PGD) SYSTEM FOR THE POINT-OF-ISSUE SCREENING OF PLATELET CONCENTRATES FOR BACTERIAL CONTAMINATION
FALSE NEGATIVE RESULTS IN THE BACTERIAL SCREENING OF PLATELET CONCENTRATES IN THE NETHERLANDS
4C-S18–01
INTEROPERABILITY OF IT SYSTEMS WITHIN TRANSFUSION MEDICINE
VALIDATION STATUS AND CHARACTERIZATION OFBLOOD ESTAB-LISHMENT COMPUTER SYSTEMS USED INPORTUGAL IN 2010
ANALYSIS OF INVENTORY POLICIES IN A REGIONAL BLOOD CENTRE USING COMPUTERIZED SIMULATION
RED CELLS: BLOOD DONOR SUFFICIENCY
4C-S19–02
TISSUES AND CELLS EXPERIENCE OF CHSUL AND CEDACE
THE USE OF FFP IN NEWBORNS, OLDER INFANTS AND ADOLESCENTS ON THE OUTCOME OF BLEEDING
FACTORS ASSOCIATED WITH ANTENATAL ANAEMIA - AUK STUDY
EVALUATION OF THE USEFULNESS OF ERYTHROCYTE SUSPENSIONS OBTAINED FROM PLACENTAL BLOODWITH CENTRIFUGATION AND HOLLOW FIBER FILTRATION METHODS FOR THE AUTOLOGOUS TRANSFUSION OF NEONATES
RATIONAL USE OF F.F.P IN NEONATES BY COMPARATIVE ASSESSMENT BETWEEN ITS TRANSFUION IN GOVERNMENTAL & PRIVATE HOSPITALS IN MENOUFIAGOVERNORATE
BLOOD REQUIREMENTS IN PEDIATRIC OPEN HEART SURGERIES: A COMPARATIVE ANALYSIS OF CYANOTIC vs. ACYANOTIC HEART DISEASE
4D-S21–01
HIGH-THROUGHPUT BLOOD GROUP GENOTYPING BYMATRIX-ASSISTED LASER DESORPTION/IONIZATIONTIME-OF-FLIGHT MASS SPECTROMETRY (MALDI-TOFMS), REPORT ON A PROTOTYPE
PERFORMANCE OF TWO NEW METHODS FOR HIGH-THROUGHPUT GENOTYPING OF BLOOD GROUPANTIGENS: IDCORE+ AND MLPA
A DNA-BASED MATCHING APPROACH THAT PREVENTSTHE ALLOIMMUNIZATION AND FACILITATES THE TRANSFUSION SUPPORT FOR SICKLE CELL DISEASEPATIENTS
ANALYSIS OF THE RHD PHENOTYPE-GENOTYPE DISCREPANCIES ENCOUNTERED DURING EXTENSIVE GENOTYPING WITH BLOODCHIP. RESULTS OF A TWO YEARS EXPERIENCE OF THE SPANISH BLOOD-CHIPUSERS GROUP (2009–2010)
TRALI INVESTIGATION INSIGHTS
DETECTION OF DONOR LEUKOCYTE-REACTIVEANTIBODIES 91 CONSECUTIVE TRALI CASES: EVALUATION OF CELLULAR-BASED vs. BEAD-BASED TECHNIQUES
TWO CASES OF TRALI FROM RED CELL CONCENTRATES CONTAINING ANTI HLA CLASS II ANTIBODIES
OLD BLOOD PRODUCTS AND TRALI
ACUTE LUNG INJURU CAUSED BY BLOOD COMPONENTS TRANSFUSION
CONTINGENCY PLANNING FOR NATURAL DISASTERS
MADRID TRAIN BOMBINGS: WHAT WE HAVE LEARNT FROM THAT SAD EVENT
PARADISE LOST -REFLECTIONS ON THE CHRISTCHURCH EARTHQUAKE
IS INTRAVENOUS IMMUNOGLOBULIN EFFECTIVE TOREDUCE EXCHANGE TRANSFUSION IN RH HEMOLYTIC DISEASE OF THE NEWBORN?
A NOVEL RHAG BLOOD GROUP ANTIGEN ASSOCIATED WITH SEVERE HDFN
A SET OF 52 SINGLE NUCLEOTIDE POLYMORPHISMS ASINDIVIDUAL INTERNAL CONTROLSIN PRENATAL BLOODGROUP TYPING
BOOSTING ANTI-D TITRES WITH RHD-DERIVED SYNTHETIC PEPTIDES CONTAINING HELPER T-CELL EPITOPES IN RHD PROTEINIMMUNISED HLA-DR15 TRANSGENIC MICE
RHCE HYBRID MOLECULES ARE MORE FREQUENT THAN PROMOTER MUTATIONS AMONG SAMPLES WITH WEAK CCEE EXPRESSION IN NORTHERN GERMANY
5A-S25–01
RED BLOOD CELL ALLOIMMUNIZATION AND NUMBER OF RED BLOOD CELL TRANSFUSIONS
EXPERIENCE WITH MASSIVE TRANSFUSION AT TWO TEACHING HOSPITALS IN SOUTH AUSTRALIA
ACTIVATION OF RED BLOOD CELL (RBC) ADHESION TO ENDOTHELIAL CELLS (EC) BY FRESH FROZEN PLASMA AND EXTRACELLULAR FLUID OF STORED RBC.
STORAGE-INDUCED PLATELET MICRO PARTICLES ENHANCE RECOMBINANT TISSUE FACTOR COAGULATION ACTIVITY
5A-S26–01
EXTENSION OF UPPER AGE LIMIT FOR BLOOD DONATION IS SAFE AND HELPS TO SATISFY THE GROWING NEEDS FOR BLOOD PRODUCTS
THE PREVALENCE OF SUB-CLINICAL IRON DEPLETIONAMONG FIRST TIME DONORS AS REFLECTED IN ZINCPROTO PORPHYRIN (ZPP) LLEVELS
SCREENING FOR HEREDITARY HEMOCHROMATOSIS INBLOOD DONORS.
TRANSFUSED DONORS
INTERNATIONAL SURVEY ON NAT TESTING OF BLOOD DONATIONS: EXPANDING IMPLEMENTATION AND YIELD FROM 1999 TO 2009
RECENT INSIGHTS IN TESTING FOR TRANSFUSION TRANSMISSIBLE VIRAL INFECTIONS
TRANSFUSION TRANSMISSION OF HEPATITIS B VIRUS:STILL LEARNING MORE ABOUT IT
NEW APPROACHES TO MANAGING: ANAEMIA
PLATELET TRANSFUSION IN THE 21ST CENTURY: WHEREWE'VE BEEN AND WHERE WE'RE GOING
NEW APPROACHES TO MANAGING: HEMORRHAGE
CONDITION AND PERSPECTIVES OF DEVELOPMENT OF BLOOD SERVICE IN TAJIKISTAN
INVENTORY MANAGEMENT - SOME ISSUES
THE BLOOD TRANSFUSION REFORM IN ALGERIA:FINANCIAL AUTONOMY
HOLISTIC MANAGEMENT & ASSESSMENT TOOL FOR BLOOD TRANSFUSION SERVICES
A METHODOLOGICAL APROACH FOR THE RETROSPECTIVE VALIDATION OF COMPUTER SYSTEMS IN USE BY THE PORTUGUESE BLOOD ESTABLISHMENTS
MICROSOFT ACCESS BASED BLOOD BANK MANAGEMENT SYSTEM
EVALUATION AND DAILY USE OF TRIMA ACCEL REPORTER, A SOFTWARE TO CAPTURE PROCEDURE DATA FROM TRIMA ACCEL®
IMPROVING PATIENT SAFETY IN BLOOD TRANSFUSION: AN INNOVATIVE APPLICATION OF INFORMATICS SYSTEM MANAGING BLOOD TRANSFUSION PROCESS
SIMPLIFYING BLOOD BANKING THROUGHTECHNOLOGY
IMPLEMENTATION OF THE TEST FOR THE QUANTITATIVE DETERMINATION OF ALANINE AMINOTRANSFERESE (ALT) IN (BLOOD) PRE DONATIONDONORS
BLOOD ESTABLISHMENT KEY PERFORMANCE INDICATORS
EVALUATION OF TRAINING & EDUCATION OF SHEBINEL-KOM REGIONAL BLOOD TRANSFUSION CENTRE(RBTC) STAFF & HOSPITAL BLOOD CENTERS & CLINICIANS
AN EDUCATIONAL APPROACH TO THE DEVELOPMENTOF A SHORT LEARNING PROGRAMME FOR NURSES INTRANSFUSION
INTRODUCTION OF THE NATIONAL BLOOD SAFETY PROGRAM
EVALUATION OF THE ROLE OF RESEARCH INTRANSFUSION MEDICINE DEVELOPMENT IN IRANIAN BLOOD TRANSFUSION ORGANIZATION
TEACHING TRANSFUSION MEDICINE IN R. MACEDONIA
ARE THE NURSES ADEQUATELY PREPARED FOR THEIR ROLE IN ENSURING SAFE BLOOD TRANSFUSIONS?
KNOWLEDGE ON TRANSFUSION MEDICINE AMONG THESTUDENTS OF THE FACULTY OF NURSING AT THEUNIVERSITY OF TIRANA
THE EFFECTS OF DOCTOR-PATIENT RELATIONSHIP IN TRANSFUSION THERAPY
EGYPTIAN FELLOWSHIP BOARD TRANSFUSION MEDICINE CURRICULUM
MEASURES TOWARDS SAFE BLOOD BANKING
THE EFFECT OF PLASMAPHERESIS ON DONORS’ ORGANISM IN HOT AND ARID CLIMATE CONDITIONS
RISK-BASED DECISION MAKING FOR BLOOD SAFETY:REPORT OF A CONSENSUS DEVELOPMENT CONFERENCE
BLOOD TRANSFUSION GUIDELINES AS A STANDARD OF MODERN PATIENT CARE
RISK BEHAVIOURS HAVING AN IMPACT ON BLOOD DONOR MANAGEMENT
DEVELOPING COLLABORATION BETWEEN BLOOD ESTABLISHMENTS, SUPPLIERS AND REGULATORS: THE “MANAGED CONVERGENCE”
MEDICAL AUDIT OF RED CELL TRANSFUSIONS IN COLOMBO SOUTH TEACHING HOSPITAL, SRI LANKA
APPLICATION OF FOCUS-PDCA AND C/T RATIO FOR OPTIMAL PATIENT'S SAFETY AND BETTER ORGANIZATION OF CLINICAL BLOOD UTILIZATION INAL WASL HOSPITAL
ASSESSMENT OF REQUISITION AND CONSUMPTION INDICES OF BLOOD IN EDUCATIONAL HOSPITALS IN NORTH EAST OF IRAN
BLOOD TRANSFUSION PRACTICE IN OBSTETRICS AND GYNECOLOGY: IMPACT OF CME PROGRAMS TO CREATE AWARENESS FOR JUDICIOUS USE OF BLOOD
ANALYSIS OF IN APPROPRIATE USE OF BLOOD PRODUCTS BY MONITORING OF TRANSFUSION REQUESTS
EVALUATION OF RED CELL TRANSFUSION PRACTICES IN PATIENTS UNDERGOING ELECTIVE SURGICAL PROCEDURES AT A SUPER SPECIALTY CENTER
OUR ROLE IN PROMOTING A BETTER UNDERSTANDING OF THE EFFICACY OF CRYOPRECIPITATE IN ACQUIRED HYPOFIBRINOGINEMIA INDUCED BY PERIOPERATIVE MASSIVE BLEEDING
ERYTROCYTE CONCENTRATE STOCK MANAGEMENT IN IMMUNO-HEMOTHERAPY SERVICE OF CENTRO HOSPITALAR COVA DA BEIRA, EPE
PRACTICAL SUGGESTION TO CARING FOR PATIENTS WHO REFUSE BLOOD TRANSFUSIONS FOR CULTURAL OR RELIGIOUS REASONS
POPULATION STUDY REGARDING THE IMPACT OF BLOOD DONATION ELIGIBILITY AND COLLECTED BLOOD UNITS VALIDATION, UPON THE TRANSFUSION SELF-SUFFICIENCY IN DIFFERENT ROMANIAN REGIONS
AUDIT OF ORDERING PRBC, PLT AND FFP AND THEIR UTILIZATION PATTERN
THE TRANSFUSION TRIGGERS AND PHYSICIAN COMPLIANCE OF RED BLOOD CELL TRANSFUSION BY COMPUTERIZED TRANSFUSION DECISION SUPPORT SYSTEM IN A MEDICAL CENTER
AN AUDIT OF COMPLETENESS OF TRANSFUSION REQUESTS IN A TERTIARY CARE ONCOLOGY CENTRE
THE ESTABLISHMENT OF HOSPITAL TRANSFUSION COMMITTEES IN HOSPITALS SRI LANKA
ESTABLISHING NATIONAL TRANSFUSION GUIDELINES IN RWANDA
MANAGEMENT ASSESSMENT OF NON-ISOGRUPAL TRANSFUSIONS HELD IN CENTRO HOSPITALAR COVA DA BEIRA FROM 2008 TO 2010
MOBILE TEAMS BLOOD COLLECTION AND THEIR ROLE IN PROVIDING AHWAZ BLOOD SUPPLY DURING 2008 UNTIL 2010
PROVIDING TIMELY AVAILABILITY OF SAFE BLOOD
TRENDS IN BLOOD COMPONENT USAGE IN FINLAND DURING 2002–2009
MOBILE BLOOD COLLECTION SCHEDULING USING MATHEMATICAL MODELING
COMPARATIVE STUDY OF CROSS MATCHED AND TRANSFUSED BLOOD IN SCHEDULED SURGICAL OPERATIONS IN A RURAL HOSPITAL OF GREECE
STOCK MANAGEMENT OF RED BLOOD CELLS - REDUCING LOSSES
REORGANIZATION OF BLOOD TRANSFUSION SERVICES: IMPROVEMENT OF BLOOD SUPPLY MANAGEMENT AND UTILIZATION IN DAKAHLIA, EGYPT
IMA BLOOD BANK OF UTTARAKHAND: SAGA OF SELFLESS SERVICE
QUALITYCONTROL IN THE SEROLOGY STUDIES WITH SERUM OF GETTING THE THIRD OPINION MAXIMUM PERMISSIBLE ERROR BY CALCULATING THE SYSTEMATIC CRITICAL ERROR CENTRAL BANK OF BLOOD XXI CENTURY NATIONAL MEDICAL CENTER
USING PROCESS IMPROVEMENT QUALITY TOOLS TO OPTIMIZE HUMAN POTENTIAL FOR APPLICATION TO BLOOD MANAGEMENT
CORRECTIVE TESTING OF IRREGULAR ANTIBODIES IN BLOOD DONORS
DEVELOPMENT OF A STEP-WISE ACCREDITATION PROGRAMME FOR AFRICAN COUNTRIES
THE BLOOD TRANSFUSION LABORATORY PRACTICE PROFICIENCY TESTING PROGRAMME IS PART OF QUALITY ASSURANCE IN THE BLOOD TRANSFUSION INSTITUTE OF SERBIA
PROFICIENCY TESTING SCHEME STUDIES TO EVALUATE BLOOD TRANSFUSION LABORATORIES PERFORMANCE
IDENTIFICATION OF SAMPLING ERRORS RESULTING IN BLOOD GROUP DISCREPANCY
PILOT EXTERNAL QUALITY CONTROL PROGRAM FOR BLOOD BANKS’ LABORATORIES IN THE COUNTRY GEORGIA
THE QUEST FOR QUALITY - THE ROLE OF BLOOD AUTHORITY INSPECTIONS
QUALITY MANAGEMENT IN THE TRANSFUSION SERVICE: SUPPORT OF OBSTETRIC SERVICES
EVALUATION OF QUALITY INDICATORS IN THE COIMBRA REGIONAL BLOOD CENTRE
THE CONTRIBUTION OF SELF-INSPECTIONS IN A BLOOD TRANSFUSION SERVICE
BLOOD COMPONENTS QUALITY CONTROL: ARE WE ACCOMPLISHING?
IMPLEMENTATION, REVIEW AND ADAPTATION OF AN ENVIRONMENT MICROBIOLOGICAL CONTROL PROGRAM - COIMBRA REGIONAL BLOOD BANK 2008–2011 EXPERIENCE
BLOOD PRODUCTS QUALITY AND QUANTITY IN THE SUMMER BLOOD COLLECTION
BLOOD DONATION IN ALMATY, KAZAKHSTAN: TRENDS AND QUALITY PERFORMANCE. ROUTINE ANALYSIS OF NATIONAL BLOOD CENTER DATA, 2005–2007
COMPARISON OF CAPILLARY AND VENOUS HEMOGLOBIN VALUES OBTAINED WITH THE HEMOCUE DONOR HB CHECKER AND SYSMEX SE 9000
TELE - RECRUITMENT : A TOOL FOR DONOR RETENTION AND IMPROVED BLOOD SAFETY
EVIDENCE THAT MIGRANT POPULATION INCREASED BETWEEN PERIODIC BLOOD AND BONE MARROW DONORS IN THE SIMTI AT THE SECOND UNIVERSITY OF NAPLES (2008–2010)
STUDY OF MOTIVES OF REGULAR NON REMUNERATED BLOOD DONORS [RNRBD], AND CAUSES OF REFUSAL OF DONATION IN SUEZ CANAL AREA, EGYPT
TRENDS OF BLOOD DONOR DEFERRAL RATES AT YAZD BLOOD TRANSFUSION CENTER DURING 2005–2009
ANALYSIS OF EFFORTS TO MAINTAIN SAFE DONOR IN MAIN DONOR POOL AFTER COMPLETION OF TEMPORARY DEFERRAL PERIOD
YOUNGER PEOPLE AND THE BLOOD DONATION IN THE REGIONAL BLOOD CENTER OF COIMBRA (RBCC)
THE SETTING-UP OF A NATIONAL REGISTRY OF BLOOD DONORS (NRBD)
THE REASONS FOR REJECTING BLOOD DONORS
BLOOD DONOR DEFERRAL CAUSES: A COMPARATIVE STUDY IN DEVELOPING AND DEVELOPED COUNTRIES
THE ROLE OF SOCIAL MARKETING IN THE RECRUITMENT, REWARD AND RETENTION OF YOUNG BLOOD DONORS
ANALYSIS OF THE CHANGE OF THE HEMOCHROME PARAMETERS IN A POPULATION OF SMOKERS DONORS
SCREENING OF THE MICROCYTOSIS INCIDENCE IN A POPULATION OF BLOOD DONORS IN NAPLES
STUDY OF MOTIVATION FACTORS AND MODES OF ACQUAINTANCE WITH BLOOD DONATION IN FIRST TIME VOLUNTARY BLOOD DONORS, IN YAZD BLOOD TRANSFUSION CENTER
REASONS FOR DECREASE THE NUMBER OF VOLUNTARY BLOOD DONATIONS IN MUNICIPALITY GEVGELIA-RETROSPECTIVE ANALYSIS OF THE FIVE YEARS PERIOD FROM 2006–2010
THE DANISH BLOOD DONOR STUDY - A NATIONWIDE PUBLIC-HEALTH STUDY
EVALUATION OF BLOOD DONATION MOTIVATIONS IN YAZD BLOOD TRANSFUSION CENTER
THE CONTRIBUTION OF VARIOUS SOURCES OF THE INFORMATION ABOUT MOSCOW BLOOD BANK FOR DONOR'S ATTRACTION
CHANGES OF BLOOD DONORS CONTINGENT STRUCTURE DURING THE TARGET PROGRAM OF BLOOD DONOR'S SERVICE DEVELOPMENT IN MOSCOW
ANALYSIS OF METALS IN THE SERUM OF PROFESSIONALLY EXPOSED POPULATION OF BLOOD-DONORS FROM THE BUCHIM-RADOVISH MINE AND UNEXPOSED GENERAL POPULATION FROM THE MUNICIPALITY OF SHTIP
DONOR-CENTRIC BLOODBANK - A NEW CONCEPT
HEMOCUE RESULTS IN FEMALE AND MALE BLOOD DONORS
A LITTLE MORE ATTENTION TO UNRELATED REPLACEMENT BLOOD DONOR
ASSESSMENT OF LEVEL OF KNOWLEDGE IN BLOOD DONORS ON SEXUALLY TRANSMITTED DISEASES WHICH ARE IMPORTANT FOR BLOOD TRANSFUSION
THE ANALYSIS OF THE EFFECT OF FACTORS ON THE GROUP BLOOD DONATION OF BEIJING
EVIDENCE OF A SYSTEMATIC HIGHER HB LEVEL IN THE CAPILLARY THAN THE VENOUS SAMPLE OF MOST DONORS
PANDEMIC FLU AND REASONS FOR DEFERRED BLOOD DONORS
APPROACH OF YOUNG PEOPLE IN SRI LANKA FOR THE BLOOD DONATION
REASONS FOR ABSOLUTE BLOOD DONORS DEFERRAL IN MOSCOW BLOOD BANK DONORS (TSARITSINO DEPARTMENT) IN 2010
REVIEW OF THE REASONS FOR BLOOD DONORS DEFERRAL IN THE FIRST SIX MONTHS OF THE YEAR 2009. AND 2010
CLUB 25 IN CONCEPCION, CHILE
TOTAL CHOLESTEROL LEVELS IN U.S. BLOOD DONORS: IMPLICATIONS FOR CARDIOVASCULAR DISEASE RISK SCREENING
HEMOGLOBIN ESTIMATION IN PRE DONATION SCREENING USING A NON-INVASIVE HEMOGLOBIN SENSOR
TREND OF REPEATED & REGULAR BLOOD DONATION & YEARLY BLOOD DONATION INDEX IN IRAN FROM 2005 THROUGH 2010
THE PATTERN OF BLOOD DONOR DEFERRAL FOR LOW HEMOGLOBIN LEVEL IN THE FOUR SEASONS
BLOOD DONATIONS IN YEAR 2010 AT THE NATIONAL INSTITUTE FOR TRANSFUSION MEDICINE IN SKOPJE - REPUBLIC OF MACEDONIA
ANALYSIS OF SOCIO-DEMOGRAPHIC STRUCTURE OF BLOOD DONORS IN REPUBLIC OF MACEDONIA FOR THE YEAR 2010
RECRUTING FIRST-TIME VOLONTEEER BLOOD DONORS TO REPEATED BLOOD DONATION
IRON STORES IN MALE BLOOD DONORS
AWARENESS OF BLOOD DONATION AMONG UNIVERSITY UNDERGRADUATES IN SOUTHERN NIGERIA
KENYA NBTS EXPERIENCE; A MARKETING COMMUNICATION APROACH TO BLOOD DONOR RECRUITMENT
DEVELOPMENT OF VOLUNTARY BLOOD DONATION IN CONCEPCION HEALTH SERVICE, CHILE
VOLUNTARY BLOOD DONATION RESULTS OF BLOOD CENTER IN CENTRAL ANATOLIA
ANEMIA SCREENING BY NON-INVASIVE HEMOGLOBIN SENSOR
STUDY OF HEREDITARY IRON DEFICIENCY IN BLOOD DONORS
PREVALENCE OF EXCLUSION CRITERIA FOR DONATION IN A REAL-WORD CENTRE FORTRANSFUSION MEDICINE
FIRST TIME DONORS WITH THALASSEMIA TRAIT IN A BLOOD BANK OUTSIDE THE THALASSEMIA BELT
BLOOD TRASFUSION CULTURE: PRESENT AND FUTURE GOALS
IS IT REALLY TRUE THAT THE DESIRE TO DONATE BLOOD IS DECREASING?
IMPACT OF INCREASING THE PROPORTION OF REPEAT DONORS, OVER A TEN YEAR PERIOD, IN THE PREVALENCE OF VIRAL MARKERS
PREVALENCE OF ANTIBODIES TO HCV IN BLOOD DONORS ORAN FROM 2000 TO 2009
FAMILY-REPLACEMENT DONATIONS IN NATIONAL INSTITUTE OF TRANSFUSION MEDICINE (NIMT) - SKOPJE
IMPROVE DONOR SATISFACTION
EXCHANGE OF VOLUMES DURING PREPARATIVE PLASMAPHERESIS
APHERESIS: A DIFFERENT APPROACH TO BLOOD DONATION
IS THERE ADEQUATE INFORMATION ON BLOOD DONATION?
VOLUNTEER BLOOD DONATION: BARRIERS AND MOTIVATIONS
THE USE OF ALYX IN THE TREATMENT OF HAEMOCHROMATOSIS PATIENTS WITH SEVERE PAIN - AN UPDATE AFTER 4 YEARS
SATISFACTION OF BLOOD DONORS AND HOW TO IMPROVE IT
VALIDATION OF INCREASED FLOW AND ANTICOAGULANT SETTINGS ON CARIDIAN BCT TRIMA ACCEL TO IMPROVE PRODUCTIVITY OF PLATELET COLLECTION
QUALITY OF APHERESIS PLATELETS SEPARATED WITH AMICUS AND TRIMA CELL SEPARATOR AND STORAGE IN PLASMA AND SSP+
A SURVEY AMONG A.V.I.S. PLASMAPHERESIS DONORS
DILUTION OF PLASMA PROTEINS DURING PLASMAPHERESIS BY INTERSTITIAL VOLUME INFLUX
VALIDATION OF THE ITRACE DATA ACQUISITION SOFTWARE IN A PLASMAPHERESIS OPERATION
EVALUATION OF ADVERSE EVENTS DURING PLATELET DONATION BY APHERESIS
EVALUATION OF NIGALE NGL XJC 2000'S PERFORMANCE IN PRODUCTIVE PLASMAPHERESIS
QUALITY CONTROLS ON PLASMA (TYPE A) COLLECTED BY NIGALE NGL XJC 2000
COMPARATIVE STUDY ON PROCEDURE TIME AND QUALITY PLASMA WITH AUTO-C TURBO MODE AND PCS2 SEPARATORS
CALCIUM AND MAGNESIUM LEVELS DURING PLATELETPHERESIS IN REGULAR DONORS: WHETHER THE NEED FOR CALCIUM SUPPLEMENTATION?
SYSTEM IMPROVEMENT: INTERNAL ASSESSMENT FOR PLATELET SECTION (2009–2010)
EVALUATION OF VACUUM BLOOD COLLECTION TUBES FOR SENDING THE NAT SAMPLES
COMPARISON OF THE TRANSFUSION EFFICACY OF MULTIPLE DOSE AMICUS PLATELET CONCENTRATES COLLECTED IN PLASMA OR PAS III ADDITIVE SOLUTION
EVALUATION OF DOUBLE RED CELL APHERESIS BY AN AUTOMATED METHOD
RETROSPECTIVE ANALYSIS OF PRE-DONATION HEMOGLOBIN SCREENING IMPLEMENTATION IN A FRENCH REGIONAL BLOOD ESTABLISHMENT (EFS PAYS DE LA LOIRE)
FOLLOW-UP OF THE DEFERRED DONORS WITH ABNORMAL TEST RESULTS
BLOOD DONATION IN THE HOSPITAL DE SÃO JOSÉ - A 11-YEAR RETROSPECTIVE ANALYSIS OF DEFERRALS AND EXCLUSIONS
WHOLE BLOOD DONOR DEFERRAL RATE
THE USE OF MEDICAMENTS AS ONE OF THE MOST FREQUENT REASONS FOR BLOOD DONOR REJECTION IN THE DEPARTMENT OF TRANSFUSION MEDICINE, GENERAL HOSPITAL STRUMICA
BLOOD DONATION: NURSES DOING THE RIGHT THING
PILOTING AN ALTERNATIVE APPROACH TO TRADITIONAL UNIVERSITY BLOOD DONATION SESSIONS
POINTS OF CARE - A SIMPLE EVIDENCE BASED MULTIDISCIPLINARY DONATION PATHWAY
DONOR RETURN RATE AFTER UNEXPECTED EVENTS DURING BLOOD AND PLASMA DONATIONS
THE PATTERNS AND RATES OF BLOOD DONOR REACTIONS DURING OR IMMEDIATELY AFTER DONATION IN KOREAN DONORS
BLOOD DONORS AND IRON DEFICIENCY
STEM CELL DONOR DEFERRALS: FREQUENCY AND REASONS
EFFECTS OF INTERVENTIONS TO REDUCE VASOVAGAL REACTIONS IN YOUNG WHOLE BLOOD DONORS ON THE DISTRIBUTION OF FAINTING ACROSS TIME COURSE OF DONATION
DONOR ADVERSE EVENTS: NEEDLE RELATED INJURIES AND VASOVAGAL REACTIONS ARE STRONGLY ASSOCIATED
ENDOCRINE ADAPTATION RESPONSE TO STRESS DURING BLOOD DONATION PROCEDURE ASSOCIATED WITH ADVERSE REACTIONS
ANALYSIS OF ADVERSE EVENTS AND PREDISPOSING FACTORS IN VOLUNTARY AND REPLACEMENT WHOLE BLOOD DONORS - A STUDY FROM NORTH INDIA
IRON STOCK DIMINUTION IN ABSENCE OF ANEMIA IN BLOOD DONORS
COMBINING HIGH DOSE VITAMIN C WITH ORAL IRON SUPPLEMANTATION FOR A MORE EFFECTIVE RISE IN SERUM FERRITIN AMONG BLOOD DONORS
ANALYSIS OF ADVERSE REACTIONS IN BLOOD DONORS RELATED TO THE DONATION OF BLOOD AND BLOOD COMPONENTS
FIRST-TIME BLOOD DONOR FINGERSTICK HEMOGLOBIN MEASUREMENTS AS A SURROGATE FOR POPULATION HEMOGLOBIN LEVELS
IS FOLATE STATUS INFLUENCED BY BLOOD DONATION?
HEMOGLOBIN EVOLUTION AMONG VERY REGULAR BLOOD DONORS
A REPORT OF AN OH PHENOTYPE CASE IN ESFAHAN AND IT'S INCIDENCE IN IRAN
BLOOD SUPPLY FOR PREGNANT PATIENT WITH HOMOZYGOUS SICKLE CELL DISEASE AND ANTI-FY3
HPA-GENOTYPED PLATELETPHERESES REPEATED DONORS DATABASE: FROM THEORY TO PRACTICE
ALTERATIONS OF THE MEMBRANA ERYTHROCYTE FOR ENZYMATIC TREATMENT
EVALUATION EFFECT OF HIGH AND LOW CENTRIFUGAL SPEED ON PLATELT AGGREGATION ACTIVITY DURING PLATELET RICH PLASMA PREPARATION
PLATELETS SUSPENDED IN SSP+ ADDITIVE SOLUTION
CLINICAL EVALUATION OF PLATELETS TREATED WITH RIBOFLAVIN AND UV LIGHT IN THE PRESENCE OF PLATELET ADDITIVE SOLUTION IN THROMBOCYTOPENIC PATIENTS
PLATELET CONTENT BEYOND THE MAXIMAL STORAGE CAPACITY OF THE CONTAINER REVEALED MITOCHONDRIAL DYSFUNCTION AND POOR PH CONTROL DURING STORAGE IN 100% PLASMA AS COMPARED WITH STORAGE IN 70% SSP+
ANALYSIS OF FUNCTIONAL ACTIVITY OF A LARGE PANEL OF COAGULATION FACTORS IN FRESH AND PREVIOUSLY FROZEN PLASMA TREATED WITH THE INTERCEPT BLOOD SYSTEM
SUBOPTIMAL STORAGE OF PLATELET CONCENTRATES (PC): CONTROL OF PLATELET QUALITY WITH NON-INVASIVE PH MEASUREMENT
CHANGES IN RED BLOOD CELLS MEMBRANE MOLECULES DURING THE STORAGE
NEW TECHNOLOGY SUPPORTING PRODUCTION OF HIGH QUALITY BLOOD COMPONENTS AND PROCESS TRACEABILITY
STUDY OF DIFFERENT FACTORS USED IN LOCAL MADE BLOOD BANK REFRIGERATORS OF IRANIAN BLOOD BANKS (IBTO) CENTERS
AUTOMATED LABELLING, PREPARATION OF CROSS-MATCH-TUBING AND RELAEASE OF BLOOD PRODUCTS
CHARACTERIZATION OF PLATELET-DERIVED MICROPARTICLES IN PLATELET CONCENTRATE
SERIAL ASSESSMENT OF BIOCHEMICAL CHANGES IN IRRADIATED RED BLOOD CELLS
ASSESSMENT OF HUMAN ERRORS IN BLOOD BANKS TAKING INTO CONCIDERATION BOTH PARAMEDICS AND NURSING STAFFS' POINT OF VIEW
AUTOMATIC BLOOD PROCESSING - OLD DEVICE WITH NEW FEATURES
THE FREQUENCY AND DISTRIBUTION OF UNEXPECTED ANTIBODIES AT TWO UNIVERSITY HOSPITAL IN CHUNCHEON, KOREA
β-GLUTATHIONYL HAEMOGLOBIN AS A BIOMARKER OF OXIDATIVE STRESS: ITS MEASUREMENT IN RED CELL CONCENTRATES
HIGHER YIELD OF BUFFY COAT PLATELETS BY EARLIER ADDITION OF PAS T-SOL
RE-INVENTING BLOOD COMPONENT PROCESSING WITH TACSI® WHOLE BLOOD: INTERNAL VALIDATION OF A COMPLETE NEW SYSTEM
ALTERATIONS THE ERYTHROCYTE HEMORHEOLOGIC PARAMETERS BY THE IN VITRO EFFECT OF THE GLUCOSE
MODELED THE CHANGES IN THE ERYTHROCYTE MEMBRANE FOR ENZYMATIC TREATMENT
ROUTINE USE OF AMICUS SOFTWARE 3.11 FOR PLATELET COLLECTION COMPARED WITH TRIMA ACCELL 5.2
VALIDATION OF BLOOD COMPONENTS PREPARED WITH THE ATREUS 3C SYSTEM
A SIMPLE METHOD TO VALIDATE A SEMI AUTOMATED SEPARATOR FOR TOP/BOTTOM BLOOD PROCESSING
FIRST VALIDATION AND IMPLEMENTATION OF THE ORBISAC SYSTEM IN A SWISS BLOOD-CENTER WITHIN THE SCOPE OF INTRODUCING THE PATHOGEN INACTIVATION SYSTEM INTERCEPT
THE IMPACT OF THE IMPLEMENTATION OF AUTOMATED WHOLE BLOOD PROCESSING SYSTEM IN TERMS OF DISCARDED COMPONENTS
STORAGE OF PLATELET RICH PLASMA AND RELEASE OF GROWTH FACTORS AND CYTOCHINES
EVALUATION OF BACTERIOLOGICAL CONTROL OF BLOOD COMPONENTS ON BLOOD BANK OF HOSPITALSÃO JOÃO, EPE
AUTOMATED JUDGMENT OF PLASMA COLOR: A PILOT
PRODUCTION OF STANDARDIZED LABILE BLOOD PRODUCTS FROM A SINGLE WHOLE BLOOD DONATION AT EFS-ALSACE BLOOD CENTER. EVOLUTION AND IMPACT OF INTERCEPT® PATHOGEN INACTIVATION TECHNOLOGY
THE USE OF ORBISAC SYSTEM: EFFECT OF AUTOMATION ON ROUTINE PRODUCTION OF POOLED PLATELETS CONCENTRATES
EFFECT OF AN OVERNIGHT HOLDING OF WHOLE BLOOD AT ROOM TEMPERATURE PRIOR TO COMPONENT PROCESSING ON THE QUALITY OF POOLED BUFFY-COAT DERIVED PLATELETS AND PLASMA
COMPARISON OF PLATELET RICH PLASMA PREPARATION METHODS FROM WHOLE BLOOD BAGSBASED ON CENTRIFUGAL FORCE
RECOVERY OF PLATELET CONCENTRATE FROM POOLED BUFFY-COATS PREPARED BY NEW TACSI™ DEVICE
EVALUATION OF THE LEVEL OF IL-1BETA, IL-6, IL-8, TNF-ALFA AND SCD40L CYTOKINES IN STORED ERYTHROCYTE AND PLATELET CONCENTRATES
PLATELET ACTIVATION OF PLATELET CONCENTRATES DERIVED FROM BUFFY COAT AND APHERESIS METHODS
STORED RED BLOOD CELLS INHIBIT PLATELET FUNCTION UNDER PHYSIOLOGIC FLOW
FLOW CYTOMETRIC AND FUNCTIONAL INVESTIGATIONS OF LIQUID STORED BUFFY-COAT DERIVED PLATELET CONCENTRATES
EVALUATION OF QUALITY CONTROL OF POOLED PLATELET CONCENTRATES PREPARED IN BTIS IN 2009, 2010
COAGULATION FACTORS V, VIII, AND X, PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME TEST RESULTS IN THAWED PLASMA STORED AT 1–6°C FOR 5 DAYS
EVALUATION THE COLORATION BETWEEN PH AND MPV IN PLATELET CONCENTRATES PREPARED IN TEHRAN BLOOD TRANSFUSION CENTER
JUSTIFICATION OR ABUSE IN IMPLEMENTATION OF FRESH FROZEN PLASMA IN OUR HOSPITALS FROM THE YEAR 2005–2010 - COMPARATIVE STUDIA
PROMOTING COST EFFECTIVE USE OF APHERESIS AND WHOLE BLOOD DERIVED PLATELET COMPONENTS THROUGH QUALITY MONITORING OF PLATELETS
IN VITRO QUALITY OF RED BLOOD CELLS COLLECTED WITH TRIMA ACCEL® AUTOMATED BLOOD COLLECTION SYSTEM VERSION 6.0
EVALUATION OF THE PERFORMANCE OF THE NEW TRIMA ACCEL® V5.2 FOR THE COLLECTION OF TRIPLE PLATELET DOSES AND PLASMA
IN VITRO EVALUATION OF APHERESIS PLATELETS CONCENTRATES STORED IN A NEW PLATELET ADDITIVE SOLUTION (PAS-IV) WITH REDUCED LEVELS OF PLASMA
PERFORMANCE COMPARISON BETWEEN LEUCOFLEX LCRD AND LCRD2 UNDER DIFFERENT PROCESSING CONDITION
LABILE BLOOD COMPONENTS COLLECTED, PROCESSED AND STORED IN DEHP-FREE CONTAINERS
THE GUIDE TO THE PREPARATION, USE AND QUALITY ASSURANCE OF BLOOD COMPONENTS OF THE COUNCIL OF EUROPE- OUTLINE OF THE 16TH EDITION AND PLANS FOR THE FUTURE
OMITTING GLYCEROL SUPERNATANT REDUCTION BEFORE FREEZING INCREASES THE RBC STABILITY AFTER THAWING
EVALUATION OF THE QUALITY OF PLATELETS IN THE PLATELET CONCENTRATE, AFTER 2, 6, 24 AND 48 HOURS AFTER WASHING WITH A SOLUTION THAT ENHANCES THE SSP+
MICROBIOLOGICAL EVALUATION OF PLATELET CONCENTRATES PRODUCED AT THE BLOOD CENTER IN POZNAN
COMPARISONOF APHERESIS AND 24 HOUR RT HELD RED CELL CONCENTRATES BY MEASUREMENT OF STORAGE LESION PARAMETERS AND NEUTROPHIL ACTIVATING FACTORS DURING 42-DAY STORAGE
PRP METHOD STILL EXISTING,STILL VERY GOOD RESULTS WITH PLATELETS
EXTENSIVE PLASMA-REDUCTION OF PLATELET CONCENTRATES LEADS TO AN INCREASE OF PLATELET ACTIVATION AND DIMINISHED PLATELET FUNCTION IN VITRO
HOW LONG CAN A PLATELET CONCENTRATE SAMPLE BE ON HOLD FOR PH, PO2, PCO2, GLUCOSE AND LACTATE MEASUREMENT?
VALIDATION OF RED CELLS AND PLASMA OBTAINED WITH A NEW INTEGRATED BLOOD SEPARATION DEVICE
IN VITRO QUALITY STUDY OF PLATELETS OBTAINED WITH A NEW INTEGRATED BLOOD SEPARATION DEVICE
A SIMPLIFIED METHOD FOR FORMALDEHYDE-CITRATE FIXATION COUNTING OF LEUKOREDUCED BLOOD COMPONENTS
FOLLOW-UP OF QUALITY CONTROL OF VIRUS-INACTIVATED PLASMA TREATED WITH METHYLENE BLUE
PAIRED IN VITRO COMPARISON OF 42- DAY RED CELL STORAGE IN BTHC AND DINCH PLASTICIZED PVC BAGS
IMPACT OF ATREUS 3C ON QUALITY OF RBC AND PLATELET PRODUCTSIN ROUTINE
COMPARISON OF TWO DIFFERENT PRODUCTION METHODS OF LEUKOCYTE DEPLETED PLASMA STORED FOR 7 DAYS AT +4°C REGARDING COAGULATION PARAMETERS AND LEVELS OF IMMUNE MODIFIERS
PLATELET PGD BACTERIAL SCREENING ASSAY FOR POINT-OF-CARE (POC) SINGLE DONOR PLATELET CONCENTRATE (SDP) TESTING PRIOR TO RELEASE
IN VITRO PLATELET FUNCTION OF PLATELET CONCENTRATES PREPARED BY BUFFY-COAT OR PRP TECHNIQUES DETERMINED BY IMPEDANCE AGGREGOMETRY
PLATELET STORAGE LESION IN PLATELET CONCENTRATES CAN BE MONITORED USING THE MULTIPLATE ANALYSER
EVALUATION OF FUNCTIONAL QUALITY OF APHERESIS PLATELET CONCENTRATES USED FOR TRANSFUSION TO HEMATOLOGICAL PATIENTS ON THE BASE OF ACTIVATION AND APOPTOSIS MARKERS
IMPROVED PLATELET COUNTS IN RANDOM DONOR PLATELET UNITS:REGIONAL EXPERIENCE, EGYPT
BLOOD COMPONENTS PREPARATION & APPROPRIATE CLINICAL USE OF BLOOD
IMPLEMENTATION OF NON-TRANSFUSED MALE DONORS PLASMA STRATEGY FOR TRANSFUSION IN THE GALICIAN TRANSFUSION CENTER
CLINICAL AUDIT OF THE USE OF FRESH-FROZEN PLASMA IN A POPULATION OF PATIENTS OF MONALDI HOSPITAL: A RETROSPECTIVE STUDY
QUALITY ASSESSMENT OF COAGULATION FACTORS AFTER PLASMA FILTRATION
HIGH EFFICACY AND ABSENCE OF THROMBOTIC EVENTS: RESULTS FROM FOUR YEARS OF USE OF PROTHROMBIN COMPLEX OCTAPLEX IN A PORTUGUESE DISTRICT HOSPITAL
CREATION OF TECHNOLOGY OF SELECTION AND PURIFYING OF BLOOD CLOTTING FACTOR VII SUITABLE FOR THERAPEUTIC USE
PREPARATION OF ALBUMIN BY HEAT DENATURATION METHOD FROM HUMAN PLASMA IN PILOT PLANT SCALE
STUDY THE EFFECT OF TEMPERATURE, TIME AND FVIII ASSAY TYPE ON FVIII ACTIVITY IN CRYOPRECIPITATE IN IRAN
STUDY ON PREPARATION OF UNIVERSAL PLASMA IN CHINESE HAN POPULATION
ANTENATAL USE OF HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR THE TREATMENT OF SEVERE HEMOLYTIC DISEASE OF THE NEWBORN
ISOAGGLUTININ TITRES VARY IN DIFFERENT BRANDS OF IV-IMMUNOGLOBULINS
AN AUDIT OF FRESH FROZEN PLASMA USAGE IN GOVERNMENT MEDICAL COLLEGE, THIRUVANANTHAPURAM
EFFECT OF MIRASOL-INACTIVATED PLASMA ON THE PRE-TRANSFUSION INTERNATIONAL NORMALIZED RATIO
CLINICAL EFFICACY OF ‘BUFFY COAT’ PLATELETS TREATED WITH RIBOFLAVIN AND ULTRAVIOLET LIGHT (MIRASOL PRT SYSTEM)
PATHOGEN REDUCTION TREATMENT USING AMOTOSALEN AND ULTRAVIOLET-A LIGHT: PROCESS CONTROL
UVC TREATMENT OF PLATELET CONCENTRATES IN THE THERAFLEX UV-PLATELETS SYSTEM ONLY SLIGHTLY AFFECTS DISULFIDE BONDS ON PLATELET PROTEINS
THE INFLUENCE OF DIFFERENTHOLDING CONDITIONS OF COAGULATION PARAMETERS OF PLASMA AFTER PATHOGEN REDUCTION WITH THE INTERCEPT TREATMENT
PREPARATION OF CRYOPRECIPITATE FROM RIBOFLAVIN AND UV LIGHT- TREATED PLASMA
QUALITY CONTROL OF PLASMA TREATED WITH TWO DIFFERENT INACTIVATION METHODS
PHOTOCHEMICAL INACTIVATION OF LYMPHOCYTES IN BLOOD USING METHYLENE BLUE WITH VISIBLE LIGHT
IN VITRO EVALUATION OF PLATELETS TREATED WITH THE THERAFLEX-UV PATHOGEN REDUCTION TECHNOLOGY
OCTAPLAS LG-SAFETY MEASURE AGAINST THE PATHOLOGICAL PRIONPROTEIN AND ITS INFECTIVITY WAS CONFIRMED BY BIOASSAY STUDIES
CLINICAL EXPERIENCE OF THE WARSAW INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE WITH PLATELET CONCENTRATES TREATED IN THE MIRASOL PRT SYSTEM
THE FLUCTUATIONS OF QUALITY PARAMETERS OF PLASMA AFTER PATHOGENS INACTIVATION BY MEANS OF MIRASOL PRT TECHNOLOGY-OWN RESEARCHES
IN VITRO EVALUATION OF PATHOGEN INACTIVATED RBC USING THE S-303 TREATMENT SYSTEM
THE COST-EFFECTIVENESS OF PATHOGEN REDUCTION TECHNOLOGY TREATMENT OF PLASMA, AND PLATELETS AND PLASMA IN POLAND
CUMULATIVE CLINICAL DATA OF INTERCEPT BLOOD SYSTEM™ FOR PLATELETS DEMONSTRATE ABILITY TO REPLACE GAMMA IRRADIATION IN ROUTINE CLINICAL USE FOR TA-GVHD PREVENTION
FEASIBILITY OF TRIPLE PLATELET (PLT) APHERESIS DONATIONS WITH THE INTERCEPT PATHOGEN REDUCTION SYSTEM
IMPACT OF INACTIVATION ON PLATELET TRANSFUSION EFFICACY
PHOTOCHEMICAL INACTIVATION OF CHIKUNGUNYA VIRUS USING THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM IN PLATELETS
PHOTOCHEMICAL TREATMENT OF FRESH PLASMA. EVALUATION OF FUNCTIONAL ACTIVITY OF COAGULATION FACTORS AND INHIBITORS
TWO YEARS OF EXPERIENCE WITH THE TRANSFUSION OF PATHOGEN INACTIVATED PLATELETS USING THE INTERCEPT BLOOD SYSTEM™ AND 7-DAY STORAGE.
A FEASIBILITY STUDY OF ORBISAC BUFFY COAT PLATELET CONCENTRATES TREATED WITH THE MIRASOL PRT SYSTEM
HEMOSTATIC EFFICACY OF PLATELET COMPONENTS TREATED WITH AMOTOSALEN-UVA PATHOGEN INACTIVATION AND STORED FOR 5 AND 7 DAYS PRIOR TO TRANSFUSION
VALIDATION OF DOUBLE DOSE POOLED PLATELET PRODUCTS FOR PATHOGEN INACTIVATION WITH THE INTERCEPT BLOOD SYSTEM AND STORAGE FOR UP TO 7 DAYS
TRANSFUSION EXPERIENCE WITH BLOOD COMPONENTS TREATED WITH THE MIRASOL®PRT SYSTEM IN THE REGIONAL BTS WARSAW
IN VITRO AND IN VIVO EVALUATION OF MIRASOL PATHOGEN REDUCTION TECHNOLOGY TREATED PLATELETS STORED IN SSP+
LYOPHILIZATION OF PLATELET BY USING IRANIAN PLATELER RICH PLASMA UNITS AND MEASUREMENTOF ITS AGGREGATION
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) ACTIVITY EVALUATION IN BLOOD DONORS IN GREECE
EFFECT OF LOWER CONCENTRATION OF DIMETHYLSULFOXIDE ON PRETREATMENT PLATELETS BEFORE LYOPHILIZATION
A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL OF RETRANSFUSION OF INTRA-OPERATIVELY COLLECTED FILTERED WHOLE BLOOD IN TOTAL HIP SURGERY WITH THE SANGVIA BLOOD REINFUSION SYSTEM
OCTAPLAS LG, UNIPLAS AND LYOPHILISED PLASMA-THREE DIFFERENT PHARMACEUTICAL FORMULATIONS OF THE SAME VIRUS INACTIVATED COAGULATION ACTIVE PLASMA
THE PLATELET GEL, THE BEARER OF GROWTH FACTORS IN THE TREATMENT OF DEGENERATIVE BONE AND JOINT DISEASES
FROZEN AUTOLOGOUS PLATELET-RICH GEL USED FOR TREATMENT OF TROPHIC ULCERATION
READY-MADE ALLOGENIC SERUM EYE DROPS FOR SEVERE DRY EYE DISEASE
ACTIVATION OF PLATELET GEL FROM FRESH PRP (PLATELET RICH PLASMA) AND RELEASE OF GROWTH FACTORS
CO-INFECTIONS OF TRANSFUSION TRANSMITED INFECTIONS AMONG BLOOD DONORS IN BLOOD TRANSFUSION INSTITUTE VOJVODINA
ESTIMATED RISK FOR TRANSFUSION TRANSMITTED INFECTIOUS DISEASES IN MEXICO
NAT SCREENING FOR HIV/HCV/HBV IN CENTRAL PORTUGAL (2006–2010)
CONSISTENCY OF DONOR RESPONSES TO CHAGAS DISEASE RISK QUESTIONS
STUDY OF PREVALENCE OF TRANSMITTED VIRAL INFECTIONS IN REGULAR AND NON-REGULAR DONORS OF YAZD BLOOD CENTER IN 1378–1388
SEROPREVALENCE OF TRANSFUSION-TRANSMITTED INFECTIONS - ARE THERE CONFIRMED BENEFITS FROM PARALLEL INVESTIGATION BY ELISA AND NAT?
EVALUATION OF PREVALENCE OF HBV ANDHCV INFECTIONIN DEFERRED BLOOD IRANIAN BLOOD TRANSFUSION ORGANIZATIONRESEARCH CENTER
PREVALENCE AND TRENDS OF INFECTIOUS MARKERS AND CO-INFECTION OF TRANSFUSION TRANSMITTED DISEASES IN NORTH INDIAN BLOOD DONORS (1999–2010)
LOW LOAD VIRAL OR FALSE REACTIVE RESULTS IN SCREENING NAT USING THE NOVARTIS TIGRIS SYSTEM / PROCLEIX ULTRIO
INDIVIDUAL DONATION TESTING (IDT) IN THE WESTERN CAPE PROVINCE OF SOUTH AFRICA USING NUCLEIC ACID AMPLIFICATION TECHNOLOGY (NAT): A 5 YEAR REVIEW
EVALUATION STUDY OF NEW COMMERCIAL SACACE TRIPLEXTEST FOR DETECTION OF HBV-DNA, HCV-RNAAND HIV-RNA
USING OF VIRUS CONCENTRATION BY CENTRIFUGATION FOR IMPROVEMENT OF THE DISCRIMINATIVE RATE OF THE UNRESOLVED NUCLEIC ACID TESTING REACTIVE SAMPLES
COMPARISON OF SEROLOGICAL MARKERS AND NAT TESTING RESULTS FOR SCREENING OF HBV, HCV AND HIV IN BLOOD DONORS
FREQUENCY OF APPEARANCE OF ANTI-HTLV-I/II ANTIBODIES IN BLOOD DONORS
SUSTAINABILITY OF CONFIDENTIAL UNIT EXCLUSION (CUE) DONATION PROCEDURE AS AN ADDITIONAL MEASURE FOR BLOOD SAFETY IN BRAZIL
HOW SAFE/UNSAFE ARE FIRST TIME DONORS IN BRAZIL?
SEROLOGIC AND MOLECULAR TYPING OF HUMAN T-CELL LYMPHOTROPIC VIRUS AMONG BLOOD DONORS FROM RIO DE JANEIRO, BRAZIL
A PROSPECTIVE STUDY FOR PREVALENCE AND OR DEVELOPMENT OF TRANSFUSION TRANSMITTED INFECTIONS IN MULTIPLY TRANSFUSED THALASSEMIA MAJOR PATIENTS
PREVALENCE OF SEROLOGICAL MARKERS OF HUMAN T LYMPHOTROPIC VIRUS TYPE I AND TYPE II (HTLV-I/II) INBLOOD DONOR POPULATION FROM NORTH AFRICA LIVING IN BALEARIC ISLANDS ARCHIPELAGO, SPAIN
CONSEQUENCES OF NAT-TMA AND SEROLOGICAL TESTING IN BLOOD PRODUCT DISPOSITION AND DONOR REFERRAL
HIGH SENSITIVITY ANTIGEN ASSAYS IN CONFIRMATION OF HIV AND HCV AG-AB COMBO TEST REACTIVITY: POSSIBLE RATIONALIZATIONOFCONFIRMATION TESTING
BLOOD DONOR SCREENING FOR CYTOMEGALOVIRUS: WHICH ASSAY IS THE BEST?
IMPROVEMENT OF THE PRE-ANALYTIC POOLING PROCESS FOR THE BUILDING OF MINI-POOLS FOR THE NAT BLOOD DONOR SCREENING
RELEVANCE OF SYPHILIS SCREENING FOR BLOOD DONATIONS -COMPARISON BETWEEN THE TPHA AND TPPA SCREENING TESTS
A STUDY ON SUITABILITY OFENHANCED CHEMILUMINESCENCE IMMUNOASSAY FOR SCREENING OF HIV, HEPATITIS B AND HEPATITIS C VIRUS IN BLOOD DONORS IN INDIAN POPULATION
RISK OF VIRAL INFECTION IN SOUTH AFRICAN BLOOD DONORS WITH NON-REPEATABLE REACTIVE RESULTS IN INDIVIDUAL DONATION TRIPLEX NUCLEIC ACID TESTING
VARIATION OF PREVALENCE OF INFECTIVE POSITIVE TEST DURING THE FIRST TWO YEAR ACTIVITY IN A NEW MEDICINE TRANSFUSION UNIT
COMMUTABILITY OF INACTIVATED OR LYOPHILISED VIRUS IN EXTERNAL QUALITY CONTROL (EQC) SAMPLES
DECADE OF VIRAL NUCLEIC ACID TESTING (NAT) IN POLAND (2000–2010); METHODS AND YIELDS
PARVOVIRUS B19 DNA TESTING IN PLASMA FOR FRACTIONATION IN POLAND, 2006–2010
ASSESSING THE COST EFFECTIVENESS OF BLOOD SAFETY INTERVENTIONS USING A WEB-BASED ANALYSIS TOOL-A PRELIMINARY ANALYSIS FOR 6 COUNTRIES
AN ALTERNATIVE WAY TO CHECK QUANTIFICATION OF VIRAL STANDARDS OF DIFFERENT GENOTYPES BY USING TWELVE YEARS RESULTS OF ANALYTICAL SENSITIVITY STUDIES OFBLOOD SCREENING NUCLEIC ACID TESTS
TRANSFUSION TRANSMITTED INFECTION SCREENING RESULTS AND RISK OF TRANSMISSION
ANTI-TREPONEMALTESTS IN BLOOD DONORS SCREENING
CORRECTIVE TESTING OF HEPATITIS B VIRUS INFECTION IN BLOOD DONORS
PREVALENCE OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS AMONG SAUDI BLOOD DONORS IN THE JAZAN REGION OF SAUDI ARABIA
PREVALENCE OF HEPATITIS B AND C CO INFECTION AMONG AHWAZ BLOOD DONORS DURING 2006–2010
EVALUATION OF COMPLEMENT COMPONENTS AND COMPLEMENT HEMOLYTIC ACTIVITYIN LIVER CIRRHOSIS
SEROPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS, HEPATITIS B AND C VIRUS INFECTIONS IN A BLOOD DONOR POPULATION: IMPACT OF NAT ON THE SAFETY OF BLOOD SUPPLY - A 9 YEAR STUDY
HEPATITIS B VIRUS (HBV) VACCINATION OF VOLUNTARY BLOOD DONORS TO IMMUNIZE THEM AND PREVENT TRANSFUSION ASSOCIATED HBV INFECTION TRANSMISSION TO PATIENTS THROUGH SAFE DONORS
TESTING FOR ANTIBODIES TO HEPATITIS B VIRUS CORE ANTIGEN AND E ANTIGEN FOR SAFER BLOOD TRANSFUSION
ACUTE HBV INFECTION IN A BLOOD DONOR OBSERVED AFTER HBV VACCINATION
CASES OF LOW HBV VIRAL LOAD (OBI) IN BLOOD DONORS, DETECTED IN BLOOD CENTER IN POZNAN WITH ROCHE COBAS TAQSCREEN MPX TEST, IN THE POOLS CONSISTING OF SIX DONATIONS, IN 2007–2010
TRANSFUSION-TRANSMITTED HBV INFECTION OF NEWBORNS THROUGH HBV CONTAMINATED RBC
OCCULT HEPATITIS B VIRUS INFECTION: DETECTION BY HBC-SPECIFICT CELL PROLIFERATION IN BLOOD DONORS WITH ANTI-HBC ALONE PROFILE
PERFORMANCE COMPARISON OF A NEW AUTOMATED ASSAY FOR HEPATITIS B SURFACE ANTIGEN
RELATIONSHIP BETWEEN GENOTYPE AND THE DEVELOPMENT OF PRECORE AND CORE PROMOTER MUTATIONS IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS
QUALIFICATION AND EVALUATION OF THE MONOLISA™ ANTI-HCV PLUS VERSION 2 TEST (BIO-RAD) FOR THE ROUTINE USE IN A GERMAN BLOOD BANK LABORATORY AND EXPERIENCE OF THE FIRST THREE MONTHS IN ROUTINE TESTING
SEROPREVALENCE OF HEPATITIS C VIRUS AMONG HEALTHY BLOOD DONORS IN RURAL POPULATION OF INDIA
PREVALENCE OF HEPATITIS C ANTIBODY AMONG VOLUNTARY BLOOD DONORS FROM THE HIGH -SCHOOL AND STUDENTS YOUTH IN GEVGELIAN-VALANDOVO REGION
DISTRIBUTION OF HEPATITIS C VIRUS GENOTYPE IN INHERITED BLEEDING DISORDERS AND THALASSEMIA IN IRAN
THE RESIDUAL RISK OF HIV AND HCV IN RUSSIAN BLOOD BANK
HCV GENOTYPES IN BLOOD DONORS OF LISBON REGIONAL BLOOD CENTRE
DIFFERENCES IN PLASMA VEGF LEVELS IN PATIENTS WITH HCV: A PILOT STUDY.LOOKING FOR A NEW BIOMARKER?
CATHEPSIN B: VIRAL INFECTION MARKER IN ASYMPTOMATIC BRAZILIAN BLOOD DONORS
CHRONIC HEPATITIS C VIRUS INFECTION DOWN-REGULATES APOPTOSIS PROGRESSION AND REDUCES OXIDATIVE STRESS INDEX
IDENTIFICATION OF HEPATITIS C PROFILES IN IRANIAN HEMOPHILIC PATIENTS
THE RETROSPECTIVE EVALUATION OF HEPATITIS B, HEPATITIS C AND HIV SEROPREVALENCEIN THE VOLUNTARY DONORS IN THE PROVINCE OF KONYA BETWEEN 2005–2010
CORRELATION OF NAT RESULTS WITH HCV SEROLOGY AND CONFIRMATORY IMMUNOBLOT TESTING
A TRIAL STUDY TO CONTROL FALSE POSITIVE RESULTS FOR HCV VIRUS IN MANSOURA REGIONAL BLOOD TRANSFUSION CENTER,EGYPT
SEROPREVALENCE OF HEPATITIS B,C AND HIV INFECTIONS IN YAZD BLOOD DONORS
SPREAD OF A NOVEL CIRCULATING HIV-1 M GENOTYPE B SUBPOPULATION IN GERMAN BLOOD DONORS MAY POSE AN INCREASED RISK TO BLOOD SAFETY
FEATURES STATE OF THE HEPATOBILIARY SYSTEM IN PATIENTS WITH HIV INFECTION IN COMBINATION WITH VIRAL HEPATITIS B AND C
EVALUATION OF HIV P24 ANTIGEN TEST IN BLOOD DONORS SCREENING FOR HIV INFECTION.
COMPARING A 3RD GENERATION ANTIBODY SCREEN ASSAY ON VITROS ECI TO A 4TH GENERATION ANTIGEN ANTIBODY SCREEN ASSAYGENSCREEN ULTRA FOR HIV ON 58,000 DONOR SAMPLES OF A TERTIARY REFERRAL CENTER IN INDIA.
RISK FACTORS EVALUATING IN INACTIVE CARRIARES OF HEPATITIS B VIRUS IN BLOOD DONORS IN TEHRAN
PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION AMONG HOSPITAL S. JOAO BLOOD DONORS SINCE THE INTRODUCTION OF NUCLEIC ACID TESTING
EPIDEMIOLOGY OF HIV, HCV AND HBV BETWEEN BLOOD DONORS: ELEVEN YEARS OF OBSERVATION
APPLICATION OF NONSPECIFIC MAGNETIC SEPARATION TECHNIQUE FOR BACTERIAL ENRICHMENT FROM CONTAMINATED PLATELET CONCENTRATES
EVALUATION OF BACTERIAL CONTAMINATION OF SDP COLLECTED AT TEHRAN (IRAN) CENTRAL BLOOD ORGANIZATION
GROWTH KINETICS OF VARIOUS BACTERIA SPECIES IN RED BLOOD CELL UNITS AFTER SPIKING WITH HIGH AND LOW BACTERIAL TITERS
BACTERIAL CONTAMINATION RATES IN APHERESIS VERSUS BUFFY COAT PLATELETS
DONOR ARM CLEANSING WITH CHLORAPREP™ REDUCES RESIDUAL BACTERIAL COUNTS, BUT MAY NOT IMPROVE BACTERIAL CONTAMINATION RATES IN PLATELET CONCENTRATES
APPLICABILITY OF A COMMERCIAL REAL-TIME PCR ASSAY, BORN FOR SEPSIS-CAUSING MICROORGANISMS IDENTIFICATION INTO THE BLOOD, TO SCREENING AND DETECTION OF BACTERIAL CONTAMINATION IN PLATELET CONCENTRATES
SUPAR AS PROGNOSTIC MARKER FOR SUBCEPTIBILITY TO BACTERIAL INFECTION: A BLOOD DONOR REGISTER STUDY
SCREENING OF CORD BLOOD DONATIONS IN 2010
VALIDATION OF EXAMINING STERILITY OF BLOOD AND BLOOD COMPONENTS BY USING BACT/ALERT APPARATUS
BACTERIAL CONTAMINATION OF BLOOD COMPONENTS: FREQUENCY AND IDENTIFICATION
THE TREND OF SYPHILITIC PREVALENCE'S IN BLOOD DONORS IN ALBANIA
ESTABLISHMENT OF THE FIRST WHO INTERNATIONAL REPOSITORY FOR TRANSFUSION RELEVANT BACTERIA REFERENCE STRAINS-ISBT WP-TTID, SUBGROUP ON BACTERIA
PROLIFERATION OF BACTERIA IN PLATELET CONCENTRATES FROM DONORS OF SEVERAL REGIONS OF THE WORLD - ISBT WORKING PARTY TRANSFUSION-TRANSMITTED INFECTIOUS DISEASES (WPTTID), SUBGROUP ON BACTERIA
GROWTH OF BACTERIA IN PLATELETS
EFFICIENCY OF THE PATHOGEN INACTIVATION SYSTEM INTERCEPT UNDER EXPERIMENTAL CONDITIONS
EVALUATION OF PLATELETS FOR BACTERIAL CONTAMINATION USING THE EBDS SYSTEM-A PILOT STUDY
EVALUATION OF TWO BACTERIAL CONTAMINATION DETECTION METHODS IN PLATELETS CONCENTRATES
RESULTS OF MICROBIOLOGICAL ENVIRONMENTAL MONITORING OF BLOOD PRODUCTION DEPARTMENT IN CROATIAN INSTITUTE OF TRANSFUSION MEDICINE
BACTERIAL CONTAMINATION: RESULTS OF A PROSPECTIVE STUDY
BACTERIAL DETECTION BY MINI POOL NAT ENABLES A COMPLETE BARCODE CONTROLLED COST EFFICIENT ALTERNATIVE TO COMMERCIAL BACTERIAL SCREENING METHODS
EXTENSION OF PLATELET SHELF LIFE FROM FOUR DAYS TO FIVE DAYS BY IMPLEMENTING OF A NEW SCREENING STRATEGY IN GERMANY
EVALUATION OF THEMALARIA PCR KIT FOR THE DETECTION OF PLASMODIUM DNA IN BLOOD DONORS AT RISK FOR MALARIA
MONITORING FOR EMERGING RISK OF BABESIOSIS IN CANADA
THE STUDY OF TEMPORARY AND PERMANENT DEFERRAL CASES OF MALARIA AND TRAVELING TO ENDEMIC AREAS IN VOLUNTEERS OF BLOOD DONATION IN YAZD IN 1387–1388
THE USEFULNESS OF PATHOGEN INACTIVATION TECHNOLOGY-A REAL LIFE EXAMPLE: INACTIVATION OF LEISHMANIA INFANTUM IN PLATELET FROM A DONOR WITH ASYMPTOMATIC INFECTION USING RIBOFLAVIN AND ULTRAVIOLET LIGHT
EVALUATION OF PLASMODIUM VIVAX ANTIGEN ENZYME-LINKED IMMUNOSORBENT ASSAY FOR SCREENING OF BLOOD
POLYMORPHISMS INVOLVED IN OXIDATIVE STRESS IN PATIENTS WITH CHAGAS DISEASE.
DEMOGRAPHIC AND SEROLOGICAL PROFILE OF BLOOD DONORS DEFERRED FOR MALARIA RISK IN A NON-ENDEMIC AREA
TO ESTABLISH A BASELINE DATA OF PREVALENCE OF HTLV-I/II INFECTION IN WESTERN INDIA BLOOD DONORS AND HIGH RISK POPULATION
EVALUATION OF WEST NILE VIRUS INFECTION FREQUENCY IN VOLUNTARY DONORS IN SISTAN_O_BALUCHESTAN PROVINCE IN IRAN
WEST NILE VIRUS NAT SCREENING IN VENETO (NORTH-ESAT ITALY)
TRANSFUSION TRANSMITTED HUMAN GRANULOCYTIC EHRLICHIOSIS
SEN VIRUS INFECTION IN IRANIAN THALASSEMIC PATIENTS
EFFICACY OF TEMPORARY EXCLUSION OF TRAVELLING BLOOD DONORS
PCR DETECTION OF HERPESVIRUSES TYPES 1,2,3,6 AND 8 IN WHOLE BLOOD OBTAINED FROM HEALTHY BLOOD DONORS OF CENTRAL GREECE
SEROPREVALENCE OF HEPATITIS E IN BLOOD DONORS IN AN ENDEMIC AREA - SHOULD WE SCREEN FOR IT?
PREVALENCE OF DIAGNOSTIC MARKERS FOR CHAGAS DISEASE IN ANDALUCÍA
TRANSFUSION TRANSMITTED WEST NILE VIRUS (WNV) INFECTION IN THALASSAEMIC PATIENTS IN GREECE
DEVELOPMENT OF A HIGH-THROUGHPUT MICRO-NEUTRALIZATION ASSAY FOR XMRV - NO EVIDENCE FOR SEROLOGICAL RESPONSES IN BLOOD DONORS
HTLV I/II INFECTION IN BLOOD DONORS: ELEVEN YEARS EXPERIENCE
RELATIONSHIP BETWEEN ABO BLOOD GROUPS AND CANCERS LOCATION INGASTROINTESTINAL TRACT
UNCOMMON ANTIBODY CASE REPORT: ANTI-SCIANNA 1
PERSISTENT A ANTIGEN AFTER STEM CELL TRANSPLANTATION OF BLOOD GROUP A PATIENT WITH NON-A DONOR
INCIDENCE OF IRREGULAR RED CELL ANTIBODIES IN VOLUNTARY BLOOD DONORS-4 YEARS EXPERIENCE
RARE PHENOTYPES OF BLOOD GROUP SYSTEMS (KIDD & MNS) AT KUWAIT CENTRAL BLOOD BANK
ASSESSMENT OF AGEING MARKERS ON RED BLOOD CELLS BY FLOW CYTOMETRIC ANALYSIS
SPECIAL PRE-TRANSFUSION SEROLOGICAL TESTING FOR PATIENTS WITH WARM TYPE AIHA
BLOOD TRANSFUSION AND ALLOIMMUNIZATIONIN PATIENTS WITH THALASSEMIA; MULTI CENTER STUDY
DELAYED HEMOLYTIC REACTIONS CAUSED BY MULTIPLE ALLOANTIBODIES-CASE REPORT
DETECTING COLD ANTIBODIES ON PATIENT WHO HAD UNDERGONE FOR SURGERY AND PREGNANT WOMEN
THE RESEARCH OF ANTIBODY IN RH ANTIGEN DEFICIENCY DC-
HYPOTHERMIC CARDIOPULMONARY BYPASS SURGERY IN A 7-YEAR-OLD BOY WITH A COLD AGGLUTININ (AUTO ANTI-IH ANTIBODY)
DISTRIBUTION PATTERN OF IRREGULAR RED CELL ALLOANTIBODIES IN PATIENT WITH THALASSEMIA MAJOR IN NORTHERN IRAN
CLINICAL SIGNIFICANT NON-D RED CELL ANTIBODIES IN PREGNANCY
A MALE PATIENT WITH THE RARE RHESUS -D- PHENOTYPE AND MULTIPLE ALLOANTIBODIES: A COMPLEX TRANSFUSION CASE
STRUCTURE AND CLINICAL SIGNIFICANCE OF POSITIVE RESULTS OF PRE-TRANSFUSION TESTING BY TUBE TEST AND GEL MICROCOLUMNS
ALLOIMMUNIZATION DUE TO TRANSFUSION - A COMARATIVE STUDY
IMPORTANCE OF SCREENING AND IDENTIFICATION OF ANTIBODIES AGAINST RED BLOOD CELL (RBC) ANTIGENES IN PRENATAL CARE IN PREGNANCY
CASE REPORT: IMMUNIZATION WITH ANTI-U IN PREGNANT WOMAN
BLOOD GROUP ERRORS AND THEIR CAUSES IN SHIRAZ BLOOD TRANSFUSION SERVICE DURING 2005–2010
THE MANAGEMENT OF FULL TERM PREGNANT WOMAN WITH RARE ANTIBODY: ANTI-S
PRELIMINARY DIAGNOSTIC STRATEGY FOR RHD TYPING IN DISCREPANT CASES IN INDIAN POPULATION
CONNECTION OF THE ABO BLOOD GROUP SYSTEM FROM THE WHOLE BLOOD GROUPS WITH THE DIABETES MELLITUS TYP 2 FOR THE PERIOD2005–2009
FREQUENCY AND CHARACTERIZATION OF RED BLOOD CELLS ANTIBODIES IN TRANSFUSED PATIENTS
EVALUATION OF ERYTRA® ANALYZER AND DG GEL® SYSTEMS IN A LARGE UK HOSPITAL
IDENTIFYING A RARE ESA ANTIBODY - MOLECULAR AND SEROLOGY STUDY
ANTI-I ALLOANTIBODY IN A PREGNANT WOMAN?
VALIDATION AND ROUTINE USE OF THE QWALYS ANTIBODIES SCREENING METHOD IN EFS (ETABLISSEMENT FRANCAIS DU SANG) ALPS - MEDITERRANEE
EVALUATION OF NEO IMMUCOR® AUTOMATED SYSTEM FOR DONOR BLOOD GROUPING
FEASIBILITY OF THE ELECTRONIC CROSS-MATCH
ANTENATAL RED CELL ANTIBODY PROFILE OF REFERRAL SAMPLES SENT TO A LARGE SPECIALIST RED CELL IMMUNOHAEMATOLOGY (RCI) DEPARTMENT IN THE UK
EVALUATION OF STATX READER, A COMPACT WORK STATION FOR USE WITH MDMULTICARD LATERAL FLOW IMMUNOHAEMATOLOGY ASSAY, IN EMERGENCY PRE-TRANSFUSION TESTING
CASE: THE INAB PHENOTYPE AND IFC ANTIBODIES: SEROLOGICAL FINDINGS AND TRANSFUSION POLICY
SMALL PHENOTYPED DONOR PANEL TO PROVIDE COMPATIBLE SAFE BLOOD TRANSFUSION TO ALLOIMMUNIZED PATIENTS
EVALUATION OF THE NEO AUTOMATED BLOOD BANK SYSTEM FOR BLOOD TYPING AND ANTIBODY SCREENING AND IDENTIFICATION
RHD TYPING IN RECENTLY AND MASSIVELY TRANSFUSED PATIENTS: THE USE OF DIFFERENT TECHNIQUES
SPECIFICITY OF ALLOANTIBODIES TO A HIGH FREQUENCY ANTIGENS DETECTED IN PATIENTS
DIFFERENCES IN RBC ALLOIMMUNIZATION BETWEEN PREGNANT WOMAN AND PATIENS IN CHC ZEMUN
DETECTION OF DUAL POPULATIONS FOR ABO AND D IN A UK NEQAS EXERCISE
DOES AUTO ANTI-GPB SUPPRESS GPB EXPRESSION?
ASSOCIATION BETWEEN GIST AND IGG PANAGGLUTINATING ANTIBODY
CHRONIC ANEMIA CAUSED BY IMMUNOGLOBULIN M INCOMPLETE WARM AUTOANTIBODIES
ANTI-RH1 IN A PARTIAL D III TYPE 5 PATIENT: A CASE REPORT
FREQUENCY OF RHESUSANTIGENS IN ALBANIAN BLOOD DONORS POPULATION.
OPTIMIZATION AND VALIDATION OF FREEZING RED BLOOD CELLS WITH HIGH GLYCEROL PROCEDURE FOR ALLOGENEIC ANTIBODIES ADSORTION
USING FROZEN RED BLOOD CELLS FOR ANTIBODIES ALLOGENEIC ADSORPTION
DRUG-INDUCED IMMUNE HEMOLYTIC ANEMIA CAUSING IMPORTANT DECREASE IN HEMOGLOBIN IN A 6-MONTH-OLD INFANT
EXTERNAL QUALITY CONTROL IN IMMUNOHEMATOLOGY: A PORTUGUESE EXPERIENCE
FREQUENCY OF MANUAL VERIFICATION WITH GEL TEST - DIAMED/ BIORAD WHEN USING THE HEMOSTMSP II TWIN SAMPLER EQUIPMENT
IMMUNOHEMATOLOGIC ANALYSIS OF TRANSFUSION DEPENDENT PATIENTS FROM A DAY HOSPITAL DEPARTMENT
DETECTION OF DEL PHENOTYPES BY AN AUTOMATED SOLID PHASE ADHERENCE METHOD
TITRATION OF ANTI-A AND ANTI-B IMMUNE ANTIBODIES: COMPARISON BETWEEN TWO TECHNIQUES: THE INDIRECT ANTIGLOBULIN TEST (IAT) (TUBE AND REFERENCE TECHNIQUE VS. GEL FILTRATION METHOD)
THE SIGNIFICANCE OF CORRECT DETERMINATION OF RARE ABO SUBGROUP OF BLOOD DONOR IN TRANSFUSION MEDICINE PRACTICE - AN ILLUSTRATION OF ONE CASE
DISTRIBUTION OF O ALLELES AND ISOAGGLUTININ TITERS IN KOREAN POPULATION
TO DETERMINE ABO, RH (D) BLOOD GROUP BLOODS OF RESIDENTS LIVINGIN ISLAND DISTRICTS TO BUILD UP POTENTIAL BLOOD DONOR GROUP
BLOOD DONOR WITH DOUBLE POPULATION: A CHIMERA
WEAK BLOOD GROUPS IN TURKEY
ALLOANTIBODIES MASKED BY AUTOIMMUNE COLD ANTIBODIES IN REGULARLY TRANSFUSED EGYPTIAN PATIENTS
IMPLEMENTATION OF A NOVEL, FULLY AUTOMATED SYSTEM FOR BLOOD TYPING FOR DONORS AT THE NBTC IN EGYPT
GENOMIC CHARACTERIZATION OF THE JK(A-B-) PHENOTYPE IN THAI BLOOD DONORS
ANALYSIS OF RHD ALLELES IN ARGENTINEANS WITH VARIANT D PHENOTYPES
EVIDENCE THAT A MUTATION IN A SPLICE SITE OF RHD INTRON 2 CAUSES ALTERNATIVE SPLICING OF RHD EXON 3
A SEROLOGICAL AND MOLECULAR SCREEN FOR WRA ANTIGEN-POSITIVE BLOOD DONORS IN SWITZERLAND
ANALYSIS OF RHCE VARIANTS AMONG 806 INDIVIDUALS IN FRANCE
SUCCESSFUL RHD ALLELIC IDENTIFICATION AMONG D-BRAZILIAN BLOOD DONORS AS A ROUTINE TEST USING POOLS OF DNA
MULTI-PARAMETRIC STUDY FOR VALIDATION OF BIOARRAY HEA BEADCHIP DNA BASED METHOD FOR DETERMINING BLOOD GROUP PHENOTYPES
ERYTROCYTE AND PLATELET GENOTYPING: THEIR UTILITY IN A BLOOD DONOR CENTER AND TRANSFUSION SERVICE
A NEW IGNT ALLELE FOUND IN THE ADULT I-NEGATIVE IN JAPANESE WITHOUT CONGENITAL CATARACTS
SEROLOGICAL AND MOLECULAR CHARACTERIZATION OF D VARIANTS IN BRAZILIANS: IMPACT FOR TYPING AND TRANSFUSION STRATEGY
DOLG, A NOVEL HIGH INCIDENCE ANTIGEN IN THE DOMBROCK BLOOD GROUP SYSTEM
NEW FUT1 MUTATIONS RESPONSIBLE FOR THE H-DEFICIENT BOMBAY PHENOTYPE: THE FIRST EXAMPLE OF AN ABOLISHED START CODON
CLINICAL VALIDATION OF A RED BLOOD GROUP GENOTYPING BEAD ARRAY
RHD VARIANTS IN POLISH BLOOD DONORS TYPED IN THE ROUTINE AS RHD NEGATIVE
RHD ZYGOSITY IN KOREANS: APPLICATION OF REAL-TIME POLYMERASE CHAIN REACTION
EVALUATION OF IDCORE+, A HIGH-THROUGHPUT RED BLOOD CELLS GENOTYPING TEST
KIDD AND COLTON GROUP SYSTEMS GENOTYPING IN AN URBAN TUNISIAN POPULATION
ON IMPROVING THE REAL-TIME PCR-BASED DETECTION OF CELLFREE FETAL DNA
DO EXTENDED-MATCHED RED BLOOD CELLS (RBC) IMPROVE TRANSFUSION YIELD?
GENOMIC TYPING OF RHD ALLELES: THREE CASES OF DOUBLE RHD VARIANTS
HPA GENOTYPING WITH IDHPA (PROGENIKA)
RED CELL ALLOIMMUNIZATION IN REGULARLY TRASFUSED PATIENTS
RED BLOOD CELL AND PLATELET ANTIGEN GENOTYPING WITH BLOODCHIP ID KITS BY PROGENIKA/GRIFOLS BASED ON LUMINEX TECHNOLOGY
BLOODCHIP GENOTYPING RESULTS OF 200 SAMPLES FROM THE CZECH POPULATION
CHARACTERIZATION OF RHD VARIANTS IN THE LISBON REGIONAL BLOOD CENTRE
HUMAN ERYTHROCYTE ANTIGEN (HEA) DETERMINATION OF 152 REAGENT RBC SAMPLES WITH HEA BEADCHIPTM DNA ANALYSIS
THE IMPORTANCE OF MOLECULAR TESTING TO IDENTIFY AND PROVIDE COMPATIBLE DONOR UNITS FOR PATIENTS WITH ANTI-HRB AND ANTI-HRS
MOLECULAR CHARACTERIZATION OF HYBRID ALLELES ASSOCIATED WITH ELEVATED D EXPRESSION: IMPORTANCE FOR PRACTICE AND TRANSFUSION SAFETY
EVALUATION OF MOLECULAR METHODS TO DETECT THE RHD*D-CE (4–7)-D VARIANT
A MULTI-CENTRE STUDY COMPARING THE PERFORMANCE OF THE BIOARRAY HEA BEADCHIP ASSAY WITH ESTABLISHED METHODS FOR DETERMINATION OF RED BLOOD CELL ANTIGENS
WEAK RHD SAMPLES AND COMPOUND HETEROZYGOSITY
INVESTIGATING PLATELET RELATED CD36 GENETIC MUTATION BY PCR-SBT
DIAGNOSTIC VALUE OF RETICULATED PLATELETS TESTING IN PRIMARY IMMUNE THROMBOCYTOPENIA PATIENTS
HUMAN PLATELETS USE MEMBRANE EXPRESSED TLR2 MOLECULES TO SECRETE A PANEL OF CYTOKINES IN A NF-? B/MYD88-DEPENDANT MECHANISM
DIFFERENTIAL PLATELET TLR4 ENGAGEMENT AND SUBSEQUENT MONONUCLEAR CELLS MOBILIZATION AFTER LPS EXPOSURE
FREQUENCY OF PLATELET ANTIBODIES IN IMMUNE DISEASES
HLA CLASS I PREVALENCE IN BLOOD DONOR POPULATION FROM PORTO BLOOD REGIONAL CENTRE (CRSP)
HUMAN PLATELET-SPECIFIC ANTIGENS FREQUENCIES AT SÃO PAULO/ BRAZIL PLATELET APHARESIS DONOR POPULATION
HPA-1, -2, -3, -5 AND HPA-15 PREVALENCE IN APHERESIS PLATELET BLOOD DONORS FROM PORTO BLOOD REGIONAL CENTRE (CRSP)
PASSIVE TRANSFER OF ISOAGGLUTININS IN INCOMPATIBLE ABO MINOR PLATELET TRANSFUSION
CONSEQUENCES OF A LACK OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DIAGNOSIS
HLA CLASS I ANTIBODIES ARE MORE COMMONLY FOUND IN PLATELET ALLOANTIBODIES THAN AUTOANTIBODIES
THE GENETIC DIFFERENCES OF HUMAN PLATELETANTIGEN BETWEEN PREGNANT WOMEN AND THEIRNEWBORNS
METHOD FOR QUICK IDENTIFICATION OF ANTI-HPA-1A ALLO-ANTI-BODIES: AUTOMATED CAPTURE P RSASSAY ON THE GALILEO ECHO.
DETECTION OF PLATELET AUTOANTIBODIES: ARETROSPECTIVE DATA ANALYSIS USING THEPAKAUTO ASSAY IN THE DIAGNOSIS OF AITP
USE OF GENOTYPING IN NEONATAL ALLOIMMUNETHROMBOCYTO PENIA
THE FREQUENCIES OF HUMAN NEUTROPHILALLOANTIGENS IN CAN-TONESE POPULATION OFCHINA
GENE FREQUENCIES OF HUMAN NEUTROPHILANTIGEN-1 IN GUANGZHOU HAN POPULATION
IDENTIFICATION OF A NOVEL MICA ALLELEMICA*002:04 BY SEQUENCING BASED TYPING ANDCLONE SEQUENCING
A PRELIMINARY STUDY OF NEUTROPHIL CD177GENOTYPE AND HNA-2 EXPRESSION IN SOUTHERNCHINA POPULATION
LEUKOCYTE-DEPLETE FILTER ELIMINATE OF NON-HEMOLYTIC TRANSFUSION REACTION
INTRAVENOUS HUMAN IMMUNOGLOBULINSTREATMENT IN A HPA-15B ALLOIMMUNIZED WOMAN:A CASE REPORT
MATERNAL PLASMA HAPTOGLOBIN AS MARKER FORFETAL HEMOLYSIS?
HOW TO CALCULATE VOLUME OF FETO-MATERNALHAEMORRHAGE
PREVENTION AND MANAGEMENT OF HAEMOLYTICDISEASE OF THE FOETUS AND NEWBORN (HDN):EXPERIENCE OF THE PROGRAM “HEALTH, WOMAN,CHILDHOOD, YOUTH” IN THE METROPOLITAN AREAOF BOLOGNA - ITALY
QUANTIFICATION OF FETOMATERNALHEMORRHAGE: A COMPARIATIVE STUDY OF THE HBFDUAL STAINING AND RHD SINGLE STAINING BY FLOWCYTOMETRY
HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ABO-INCOMPATIBILITY. LACK OF ACTIVATION OF THECOMPLEMENT SYSTEM
SEVEN YEARS EXPERIENCE IN KUWAIT NATIONALANTENATAL PROGRAM
DETECTION AND QUANTIFICATION OF FETO-MATERNAL HAEMORRHAGE (FMH) BY TWO FLOWCYTOMETRIC TESTS
DIFFICULTIES IN NON-INVASIVE PRENATAL RHDGENOTYPING IN ALLOIMMUNISED WOMANAFTER ALLOGENEIC HAEMATOPOIETIC STEM CELLTRANSPLANTATION
DIAGNOSTICS AND PREVENTION OF HAEMOLYTICDISEASE OF FETUS/ NEWBORN (HDFN)? EXPERIENCEIN SLOVENIA
OVODONATION FOR IN VITRO FERTILIZATIONCREATING IMMUNOHE-MATOLOGIC PROBLENS, APOSSIBLE CAUSE OF HEMOLYTIC DISEASE OFNEWBORN
COMPARISON OF THE INTENSITY OF ANTI-RH1DETECTION USING GALILEO (IMMUCOR) AND GELMICROTITRATION: A SEMI QUANTITA-TIVEAUTOMATED APPROACH TO DETERMINE THE ORIGINOF ANTI RH1.
SEVERE NEONATAL ALLOIMMUNE NEUTROPENIA INA NEWBORN DELIVERED BY A CD16 DEFICIENT GYPSYWOMAN
IMMUNOHEMATOLOGICAL CONTROL PRENATALRH(D) IMMUNE GLOBULIN PROPHYLAXIS
RBC AND HLA IMMUNIZATION IN BLOOD DONORS ATTHE LISBON REGIONAL BLOOD CENTRE
A FATAL TRALI CASE INDUCED BY HLA CLASS I ANDCLASS II ANTIBODIES PRESENT IN A FFP UNIT FROM AFEMALE DONOR
INTRAUTERINE BLOOD TRANSFUSIONAS A METHODOF TREATMENT OF HEMOLYTIC DISEASE OF FETUSAND NEWBORN
THE USE OF ERYTHROCYTE CONCENTRATE ANDFRESH FROZEN PLASMA AT THE DEPARTMENT OFPAEDIATRICSIN THE GENERAL HOSPITAL STRUMICAIN THE YEAR 2010
HYPERHEMOLYSIS SYNDROME IN PEDIATRICPATIENTS WITH SICKLE CELL DISEASE: POSSIBLEINFECTIOUS ETIOLOGY?
HEMOLYTIC DISEASE OF THE NEWBORN ASSOCIATED WITH ATYPI-CAL ERYTHROCYTE ANTIBODIES
AN EVALUATION OF GLUCOSE-6-PHOSPHATEDEHYROGENASE (G6PD) DEFICIENCY IN BLOODDONORS IN MAZANDARAN PROVINCE, IN IRANBYSPOT TEST AND ENZYMATIC METHODS
FIRST FULL TERM PREGNANCY OF A MOTHER WITHBOMBAY BLOOD GROUP (OH) IN FINLAND - THEIMPORTANCE OF INTERNATIONAL CO-OPERATION
ALLOGENEIC CORD BLOOD RED CELLS FORTRANSFUSION
EFFICACY OF USING PACKED RED BLOOD CELL WITHSATELLITE BAGS IN THE NEWBORNS TRANSFUSIONS
HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINTHERAPY FOR HYPERBILIRUBINEMIA DUE RHHEMOLYTIC DISEASE: A RANDOMIZED CLINICALTRIAL
OPTIMAL USE OF BLOOD COMPONENTS IN NEWBORN
TREATMENT BY ERYTHROCYTAPHERESIS OF IRONOVERLOAD AFTER ALLOGENEIC BONE MARROWTRANSPLANTATION
DEVELOPING EVIDENCE BASED AUTOMATED RED CELL EXCHANGE PROGRAMME IN THE EASTERN PROVINCE OF SAUDI ARABIA
PLASMA EXCHANGE ROLE IN MYASTHENIA GRAVIS TREATMENT
THERAPEUTIC PLASMA EXCHANGE - CENTRIFUGALAND FILTRATION TECHNIQUES USED IN THETREATMENT OF A PATIENT WITH MULTI-PLESCLEROSIS
THERAPEUTIC APHERESIS PROCEDURES IN 2005–2010 PERIOD
ASSESSING ROLE OF THERAPEUTIC PLASMAEXCHANGE IN VARIED CLINICAL CONDITIONS
SCOPE AND APPLICATION OF THERAPEUTICAPHERESIS: EXPERIENCE FROM COST CONSTRAINEDSETTINGS IN A TERTIARY CARE HOSPITAL IN NORTHINDIA
THERAPEUTIC PLASMAPHERESIS FOR TTP
TREATMENT OF THE RELAPSE OF THROMBOTICTHROMBOCYTOPENIC PURPURA USIGNTHERAPEUTIC PLASMA EXCHANGES - CASE REPORT
PLASMA EXCHANGE IN A CASE OF PEG-ASPARAGINASE INDUCED HYPERTRIGLYCERIDEMIA
THROMBOTIC THROMBOCYTOPENIC PURPURA:OVERVIEW ON THE LAST 10 YEARS OF PLASMAEXCHANGE TREATMENT IN HOSPITAL SÃO JOSÉ,LISBON
PLASMA EXCHANGE FOR NEUROLOGICAL DISEASES
EMERGENCY THERAPEUTIC LEUKAPHERESIS INADULT CHRONIC MYELOYD LEUKEMIACOMPLICATED BY LEUKOSTASIS: A CASE REPORT
UNEXPECTED SIDE EFFECTS WITHOUTHYPOCALCEMIA DURING THERAPEUTIC PLASMAEXCHANGE
APHAERESIS PROCEDURES - DATA FROM BANCO DESANGUE DE SÃO PAULO / BRAZIL
DECREASE IN RED CELL TRANSFUSION AFTERENFORCEMENT OF TRANSFUSION GUIDELINES
DENGUE PANDEMIC: BLOOD BANKS TO THE RESCUE
BLOOD UTILIZATION ANALYSIS IN PRIMARY CABGSURGERIES
OVERVIEW OF BLOOD COMPONENT USAGEAT ACENTRAL HOSPITAL
VALUE OF CONTROL OF HEMOSTASIS SYSTEM IN ITTAND DISSEMI-NATED INTRAVASCULAR COAGULATIONSYNDROME
IMPORTANCE OF BLOOD TRANSFUSION IN MILESABDOMINOPERINEAL RESECTION (APR) OF RECTUMCANCER
ANAEMIA AND BLOOD TRANSFUSION PRACTICE INELECTIVE ORTHO-PAEDICS SURGERY PATIENTS
TRANSFUSION OF RHD NEGATIVE PATIENTS WITHRHD POSITIVE RED CELLS CONCENTRATES - THEHPFF, EPE; BLOOD DEPARTMENT EXPERIENCE (2002–2010)
RELATIONSHIP BETWEEN TRANSFUSIOLOGICALACTIVITY AND HIGH-TECH OPERATIONS INHOSPITALS OF BELARUS
UTILIZATION OF BLOOD INGASTROENTEROHEPATOLOGY
IDENTIFICATION OF ABNORMAL HEMOGLOBINVARIANTS AMONG BLOOD DONORS
OPTIMAL USE OF BLOOD GUIDANCE FORTRANSFUSION OF RBC, PC AND PLASMA IN CAPEVERDE
PLATELET CONSUMPTION IN ONCOHEMATOLOGICALPATIENTS - A CENTER EXPERIENCE
TYPE AND SCREEN TESTING FOR SURGERY IN ANONCOLOGY CENTER
BLOOD USE IN STEM CELL TRANSPLANTATION
D VI PARTIAL - CAUSE OF IMMUNIZATION AFTERBLOOD TRANSFU-SION - CASE REPORT
THE NECESSITY OF BLODD AND BLOOD COMPONENTSIN THE CLINICAL HOSPITAL - TETOVO DURING THEYEAR 2010
COMPARATION OF BLOOD TRANSFUSION USE IN LIVER SURGERY METHODS-RADIOFREQUENCY ASSISTED RESECTION (RFAR) VS. WATER JET LIVER RESECTION
PATIENT BLOOD MANAGEMENT GUIDELINES FOR AUSTRALIA
INITIATING A PROGRAM FOR TRANSFUSION SUPPORT IN LIVER TRANSPLANTATION-OUR EXPERIENCES
TRANSFUSION THERAPY AND SICKLE CELL DISEASE
USE OF RED BLOOD CELLS AND IRON PREPARATIONS AT THE OBSTETRICS DEPARMENT
TRANSFUSION OF POOLED RANDOM PLATELET CONCENTRATES (PRPC) AND APHERESIS PLATELET CONCENTRATES (APC) IN ADULT OF HEMATOLOGY DEPARTMENT INTHE UNIVERSITY HOSPITAL OF RENNES.
BLOOD TRANSFUSION IN CARDIAC SURGERY IN CHLO-HOSPITAL DE SANTA CRUZ
PATTERN OF PLATELET USE IN A COHORT OF SRI LANKAN ADULT PATIENTS WITH DENGUE HAEMORRHAGIC FEVER
THE USE OF BLOOD COMPONENTS IN CARDIAC SURGERY IN THE PERIOD1998–2010
PREVALENCE OF DIABETES MELLITUS IN TRANSFUSION DEPENDENT BETA THALASSEMIAPATIENTS, CASE STUDY IN REGIONAL TRANS-FUSION CENTER IN DAKHLIA, EGYPT
CHANGING MANAGEMENT IN MASSIVE BLEEDING SANTA MARIA HOSPITAL (HSM) EXPERIENCE
TREATMENT WITH FIBRINOGEN CONCENTRATE IN A PATIENT WITH SEVERE POSTPARTUM HAEMORRAGHE
EFFECT OF REDUCING PROPHYLACTIC PLATELET TRANSFUSION DOSE ON BLEEDING IN THROMBOCYTOPENIA PATIENTS
FUNCTIONAL QUALITY CONTROL OF PLATELET CONCENTRATES PREPARED FROM ‘BUFFY COAT’
PREVALENCE OF FACTOR VIII INHIBITOR IN HAEMOPHILIA- A PATIENTS AT A TERTIARY CARE HOSPITAL IN NORTH INDIA
PLASMA TREATMENT OPTIONS FOR PATIENTS WITH HEREDITARY FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA
HAEMOSTATIC DISORDERS AT PATIENTS WITH DECOMPENSATED HEPATIC CIRRHOSIS
HUMAN PLASMA DERIVED PROTHROMBIN COMPLEX CONCENTRATE (OCTAPLEX®), THE HPFF, EPE - BLOOD DEPARTMENT EXPERIENCE
ESTABLISHMENT OF A CHO CELL EXPRESSING RECOMBINANT HUMAN COAGULATION FACTOR VII FUSED TO A HISTIDINE TAG
EVALUATION OF IMPLEMENTATION OF GUIDELINES FOR LABORA-TORY TESTING FOR HEPARIN INDUCED THROMBOCYTOPENIA IN CROATIAN INSTITUTE OF TRANSFUSION MEDICINE IN THE PERIOD FROM 2008 TO 2010
PLATELET DYSFUNCTION AND BORDERLINE THROMBOCYTOPENIA-TWO CASE REPORTS
WOMEN PLASMA TRANSFUSIONS ARE MORE OFTEN ASSOCIATED WITH PNEUMONIA
USE OF ORAL CHELATOR-DEFERASIROX-IN IRON OVERLOAD PA-TIENTS
TRANSFUSION TREATMENT AND PREVENTION OF THE ANAPHYLACTIC TRANSFUSION REACTION OCCURRENCE IN PATIENTS WITH LOW CONCENTRATION OF IGA - CASE REPORT
MORTALITY AFTER SEX-MISMATCHED TRANSFUSIONS
TRANSFUSION RELATED NON-INFECTIOUS COMPLICATION: IMPLICATION FOR AN APPROPRIATE REPORTING (HAEMOVIGILANCE) SYSTEM
CORRELATIONS BETWEEN FREQUENCY OF BLOOD TRANSFUSION AND TRANSFUSION REACTIONS IN PATIENTS WITHOUT PRIOR TRANSFUSION HISTORY
5 YEARS OF HAEMOVIGILANCE REPORTING TO THE DESIGNATED UK COMPETENT AUTHORITY: SABRE 2005–2010
HOW A “HUMAN FACTORS” APPROACH CAN IMPROVE UNDERSTANDING OF WRONG BLOOD IN TUBE (WBIT) EVENTS IN EMERGENCY DEPARTMENTS
TRANSFUSION ADVERSE REACTIONS AND EVENTS IN CROATIA
VARIATION BETWEEN HOSPITALS IN RATES OF REPORTED TRANSFUSION REACTIONS: DO MORE REPORTS INDICATE THAT TRANSFUSION IS SAFER?
TRANSFUSIONAL SAFETY WITH RFID TECHNOLOGY (EXPERIENCE AT IPOLFG)
BIOBANKING
EVALUATION OF ERRORS IN THE ADMINISTRATION OF COMPONENTS IN A UNIVERSITY HOSPITAL HAEMOVIGILANCE PROGRAM
CONNECTION BETWEEN PHARMACOVIGILANCE AND HAEMOVIGILANCE
HEMOVIGILANCE IN BRAZIL: SOME RESULTS AND PERSPECTIVES
REPORTING AND ANALYSING NEAR MISS EVENTS: A STEP TOWARDS BLOOD SAFETY
INTRODUCING GOVERNMENT-SUPPORTED HEMOVIGILANCE SYSTEM IN KOREA
THE BOTIA PROJECT (BLOOD AND ORGAN TRANSMISSIBLE INFECTIOUS AGENTS): A EUROPEAN COLLECTION OF DONOR/RECIPIENT BLOOD SAMPLES AS AN OBSERVATORY TOOL FOR TRANSFUSION-TRANSMITTED AGENTS
RECORDING AND INVESTIGATION OF ADVERSE EVENTS AND NEARMISS EVENTS LEADING TO ENHANCED SAFETY OF TRANSFUSIONS
FOLLOW-UP OF RED BLOOD CELL TRANSFUSIONS IN HEMATOLOGY PATIENTS AND ITS IMPACT ON TRANSFUSION PLANNING
BENEFIT OF TRALI RISK REDUCING MEASURES - GERMAN HAEMOVIGILANCE DATA
FEBRILE NON-HAEMOLYTIC POSTTRANSFUSION REACTIONS - THREE YEARS OF EXPERIENCE
TRANSFUSION SAFETY: HAEMOVIGILANCE
ABO DISCREPANCIES BY USURPATION IDENTITYT: A NEW CHALLENGE FOR TRANSFUSSION MEDICINE DEPARTMENTS
STRATEGIES FOR REDUCING BLOOD TRANSFUSION AT A HOSPITALOF YAZD, IRAN
EVALUATION OF IMMUNE RESPONSE TO PNEUMOCOCCAL VACCINE IN VACCINATED SPLENECTOMIZED THALASSEMIC PATIENTS
PERSISTENT HEMOLYSIS IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT
INTRAVENOUS FERRIC CARBOXYMALTOSE - FeCarb -(FERINJECT ®): IT'S USE IN FERROPENIC ANAEMIA
INDICATORS OF CENTRAL HAEMODYNAMICS OF PREGNANT WOMEN, BEFORE AND AFTER OPERATIVE PERIODS WITH AUTODONOR OF PLASMA
USE OF AUTOLOGOUS AND ALLOGENIC BLOOD IN ABDOMINAL AORTIC ANEURYSM SURGERY IN GENERAL HOSPITAL UZICE (3 YEAR EXPERIENCE)
THE EFFECT OF EXERCISE ON DEMAND OF HAEMOPHILIC PATIENTS TO FACTOR VIII CONCENTRATES: A SYSTEMATIC REVIEW
MANAGEMENT OF IRON DEFICIENCY ANEMIA IN THE MULTIFIELD HOSPITAL
TRANSFUSION STRATEGY IN ELECTIVE ORTHOPEDIC SURGERY (3 YEARS EXPERIENCE)
INTRAOPERATIVE AUTOREINFUSIONS EXPERIENCE IN RUSSIAN REGIONAL CLINICAL HOSPITAL
TRANSFUSION TECHNIQUE FOR MAJOR JOINTS ENDOPROSTHESIS REPLACEMENT
INHERITED COAGULATION DEFICIENCY WITH FACTOR X IN SURGICAL PATIENT - TRANSFUSIOLOGICAL VIEW
PREOPERATIVE AUTOLOGOUS BLOOD DONATION IN PATIENTS WITH PROSTATIC ADENOMECTOMY AND/OR TRANSURETHRAL RESECTION
ROMIPLOSTM EFFICACY IN AN ACUTE MYELOID LEUKAEMIA PATIENT WITH TRANSFUSION REFRACTORY THROMBOCYTOPENIA
METHODS OF CRYOPRESERVATION OF CORD BLOOD HEMATOPOIETIC STEM CELLS
MICRO RNA MICROARRAY PROFILING IN HUMAN MEGAKARYOCYTIC DIFFERENTIATION OF UMBILICAL CORD BLOOD CD133+ CELLS
CORD BLOOD TOTAL NUCLEATED AND CD34+ CELL RECOVERY AFTER VOLUME REDUCTION USING SEPAX AUTOMATED SYSTEM
CORD BLOOD HEMATOPOIETIC STEM CELLS EXPANSION IN COCULTURE WITH MESENCHYMAL STEM CELLS AND COPPER CHELATOR
TGFBR2 KNOCK DOWN BY RNAI INCREASES LT-CIC FREQUENCY OF CORD BLOOD CD34+ HSCS
EXPRESSION OF THE CYCLIN-DEPENDENT KINASE INHIBITORS P15 (INK4A) AND P16 (INK4B) DURING EX VIVO CORD BLOOD HEMATOPOIETIC STEM CELL EXPANSION
IMPACT OF THE CELLULAR CONTENT OF LEUCOREDUCTION SYSTEM (LRS) CHAMBERS ON STEM CELL RESEARCH AND APHERESIS PROCEDURES
THE ROLE OF CXCR1/CXCR2 RECEPTORS ON POLYPLOIDIZATION OF HUMAN UMBILICAL CORD BLOOD -DERIVED MEGAKARYOCYTE PROGENITOR CELLS
DETECTION AND ANALYSIS OF CD271, CD133 A ND CD34EXPRESSIONS IN BONE MARROW CELLS BY FLOW CYTOMETRY WITH THREE COLOR FLUORESCENCE LABELLING
CORRELATION BETWEEN HAEMATOPOIETIC STEM CELL PARAMETERS AND HLA-A, -B AND -DRB1 POLYMORPHISMS IN 1206 CAUCASIAN NEWBORNS BELONGING TO THE PAVIA CORD BLOOD BANK
VIABILITY, CLONOGENICITY AND CYTOCHEMICAL QUALITY OF BLOOD PROGENITOR CELL PRODUCTS
PLERIXAFOR(AMD3100) USEFULLYIN POOR MOBILIZERS PATIENTS
PLERIXAFOR(AMD3100) USEFULLYIN ‘NOVO’ (FIRST) MOBILIZATIONS
CONTROLLED VS. UNCONTROLLED RATE CRYOPRESERVATION OF PERIPHERAL BLOOD STEM CELLS (PBSC). HSM BLOOD TRANSFUSION CRYOBIOLOGY LABORATORY EXPERIENCE
AUTOLOGOUS PERIPHERAL BLOOD STEM CELL COLLECTION AT THE WARSAW INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE
ASSESSMENT OF THE EFFECTS OF TEMPRATURE AND TIME ON HSCS SPECIMENS SEPARATED FROM UMBLICAL CORD BLOOD DURING TRANSPORTATION AND STORAGE
COMPARISON BETWEEN CELL VIABILITY TESTING PERFORMED AFTER THAWING IN SATELLITE SAMPLES AND CORRESPONDING FROZEN BAGS
NURSING CARE DURING PERIPHERAL BLOOD STEM CELL (PBSC) COLLECTION
DO WE NEED HYDROXYETHYL STARCH TO DEPLETE RED BLOOD CELLS FROM HEMATOPOIETIC PROGENITOR CELLS?
HIGHER INITIAL DMSO CONCENTRATIONS AFFECTS VIABILITY OF HEMATOPOIETIC PROGENITOR CELLS
RAPID DETECTION OF MICROBIAL CONTAMINATION OF CELL BASED PRODUCTS BY COMBINATION OF MEMBRANE FILTRATION AND FLUORESCENCE STAINING OF MICROCOLONIES
ENUMERATION OF VIABLE CD34+ CELLS BY FLOW CYTOMETRY IN BLOOD, BONE MARROW AND CORD BLOOD: RESULTS OF A STUDY OF THE NOVEL BD™ STEM CELL ENUMERATION KIT
INFLUENCE OF THE CRYO-PROTECTANT DMSO ON THE DETECTABILITY OF BACTERIA IN STERILITY TESTING OF CELL THERAPEUTICS
HOW HEALTHY ARE MATCHED UNRELATED STEM CELL DONORS?
DIFFERENCES BETWEEN AUTOLOGOUS AND ALLOGENEIC PERIPHERAL BLOOD PROGENITOR CELL COLLECTIONS USING A NOVEL AUTOMATED APHERESIS SYSTEM
INFLUENCE OF HIGH INLET FLOW RATES ON EFFICACY OF STEM CELL APHERESIS USING THE SPECTRA OPTIA® APHERESIS SYSTEM
ASSESSING THE DURATION OF STORAGE AND EXPIRATION DATE OF CRYOPRESERVED CORD BLOOD UNITS
COLLECTION AND FOLLOW-UP OF UNRELATED DONORS OF HAEMATOPOIETIC STEM CELLS AT IPO PORTO
QUALITY CONTROL OF UNRELATED HAEMATOPOIETIC GRAFTS RECEIVED FOR PATIENTS IN IPO PORTO
THE ROLE OF MYELOMA CELLS IN OSTEOCLAST ACTIVATION
THE USE OF AUTOLOGOUS TRANSPLANT IN APLASTIC ANEMIA: CORRELATION OF CD34+/CD90+ CELLS APPLIED AND CLINICAL OUTCOME
RECOMBINANT HUMAN ERYTHROPOETIN AT TRANSFUSION THERAPY IN THE KIDNEY TRANSPLANTATION
PERCUTANEOUS INJECTION OF AUTOLOGOUS BONE MARROW CELLS AND PLATELET RICH PLASMA GEL IN THE TREATMENT OF BONE CYSTS
HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL (PBSC) IN ADULT TRANSPLANTATION (TX) WITH CLINIMACS SYSTEM: HOSPITAL SANTAMARIA (HSM) EXPERIENCE
COLLECTION AND TRANSPLANTATION OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE
GMP COMPLIANT ISOLATION OF UNTOUCHED CMV-SPECIFIC DONOR DERIVED CD3+CD8+ T LYMPHOCYTES USING STREPTAMER-TECH-NOLOGY
CHEMOKINE RECEPTORS CAN REGULATE PROLIFERATION OF HEMATOPOIETIC STEM CELLS
THE RESTRICTION HLA-DR, -DQ MOLECULES IN HIGH PLATELET TRANSFUSED PATIENTS WITH HEMATOLOGICAL DISORDERS
PREVALENCE OF HLA ANTIBODIES IN POST PREGNANCIES FEMALE BLOOD DONORS
COMPARISON OF HLA ALLOSENSIBILIZATION IN PREGNANCY IMMUNIZED BLOOD DONORS AND POLYTRANSFUSED HEMATOLOGICAL PATIENTS
PHENOTYPIC HLA CHARACTERISATION AND ETHNIC FEATURES OF UMBILICAL CORD BLOOD IN MEXICAN PATIENTS
KIR (KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTOR) RECEPTORS AND GRAFT-VERSUS-HOST DISEASE(GVHD) IN STEM CELL TRANSPLANT
STUDY OF OSTEOGENIC GENE EXPRESSION IN OSTEOBLASTIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
KIR-HLA LIGAND DEPENDENT NATURAL KILLER CELL MEDIATED ALLOREACTIVITY IN HAPLOIDENTICAL CD19/CD3 DEPLETED STEM CELL TRANSPLANTATION.
DISTRIBUTION OF MICA ALLELES AND HAPLOTYPES ASSOCIATED WITH HLA IN A SOUTHERN CHINESE HAN POPULATION
DESENSITIZATION PROTOCOL WITH IMMUNOADSORPTION AND RITUXIMAB IN A PATIENT WITH DONOR-SPECIFIC HLA-ANTIBODIES UNDERGOING HEART TRANSPLANTATION
METHODOLOGIES FOR ANTI HLA ANTIBODIES SCREENING IN PATIENTS AWAITING FOR KIDNEY TRANSPLANTATION: A COMPARATIVE STUDY
A NOVEL IN VITRO ASSAY OF SERUM FROM HLA-SENSITIZED PATIENTS AFTER TREATMENT WITH INTRAVENOUS HUMAN GAMMAGLOBULIN
A NOVEL HIGH-THROUGHPUT PLATFORM (DYNACHIP) FOR HLA ANTIBODIES DETECTION IN PATIENTS AWAITING FOR ORGAN TRANSPLANTATION
ASSESSMENT OF NEW LIAISON® XL MUREX AUTOMATED IMMUNOASSAYS FOR DETECTION OF HBSAG, ANTI-HCV AND HIV MARKERS IN HUMAN SERUM/PLASMA SPECIMENS
ENHANCED AGGLUTINATION REACTION OF ABO SUBGROUPS BY GOLD NANOPARTICLE SOLUTION: IMPLICATION FOR IDENTIFICATION OF ABO SUBGROUPS
EVALUATION THE EFFECT OF MIR-155 INHIBITOR ON HEMOGLOBIN ALPHA CHAINS EXPRESSION IN K562 CELLS
ABH SECRETOR STATUS AND GAMETE INTERACTION. CLINICAL SIGNIFICANCE ON REPRODUCTIVE OUTCOME
MEASUREMENT OF HBA2 USING AUTOMATED CATION- EXCHANGE CHROMATOGRAPHY TO DETECT B-THALASSEMIA TRAIT
CELLBIND SCREEN AND MAGISTER IN THE DAILY ROUTINE OF THE CLINICAL LABORATORY
THE INFLUENCE OF REGIONAL HUMAN DEVELOPMENT FACTORS ON THE STATE OF BLOOD DONATION IN ZHYTOMYR REGION
RELEVANCE OF BLOOD GROUP GENOTYPING PRODUCT FLEXIBILITY
IDRHD, A HIGH-THROUGHPUT GENOTYPING TEST FOR D- DONOR CONFIRMATION
ALLOGENIC TRANSFUSION VS. POSTOPERATIVE BLOOD RECOVERY USING CELLTRANS SYSTEM: COMPARISON OF RESULTS FOLLOWING TOTAL KNEE AND HIP ARTHROPLASTY
Corrigendum